Information  X 
Enter a valid email address

Glaxosmithkline PLC Ord 25P (GSK)

Date Time Source Announcement
21 Feb 2020 1:00 pm
RNS
Director/PDMR Shareholding
20 Feb 2020 3:30 pm
RNS
Director/PDMR Shareholding
  2:00 pm
RNS
Director/PDMR Shareholding
  2:00 pm
RNS
Director/PDMR Shareholding
19 Feb 2020 5:25 pm
RNS
Director/PDMR Shareholding
  4:35 pm
RNS
Director/PDMR Shareholding
  4:28 pm
RNS
Director/PDMR Shareholding
  4:24 pm
RNS
Director/PDMR Shareholding
  4:17 pm
RNS
Director/PDMR Shareholding
12 Feb 2020 5:05 pm
RNS
Director/PDMR Shareholding
11 Feb 2020 2:15 pm
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Transfer of Treasury Shares
06 Feb 2020 4:00 pm
RNS
Director/PDMR Shareholding
05 Feb 2020 4:15 pm
RNS
Director/PDMR Shareholding
  12:00 pm
RNS
Final Results
03 Feb 2020 3:15 pm
RNS
GSK publishes provisional 2020 Dividend Dates
  9:30 am
RNS
Total Voting Rights
15 Jan 2020 7:00 am
RNS
Director/PDMR Shareholding
14 Jan 2020 4:46 pm
RNS
Director/PDMR Shareholding
  4:01 pm
RNS
Director/PDMR Shareholding
13 Jan 2020 6:00 pm
RNS
Director/PDMR Shareholding
  11:41 am
RNS
Director/PDMR Shareholding
  11:01 am
RNS
Director/PDMR Shareholding
  10:34 am
RNS
Director/PDMR Shareholding
08 Jan 2020 4:30 pm
RNS
GSK publishes provisional 2020 Dividend Dates
  2:37 pm
RNS
GSK Announces addition to Corporate Executive Team
02 Jan 2020 9:58 am
RNS
Total Voting Rights
23 Dec 2019 7:01 am
RNS
ViiV Healthcare receives complete response letter
18 Dec 2019 5:12 pm
RNS
Director/PDMR Shareholding
  4:55 pm
RNS
Director/PDMR Shareholding
17 Dec 2019 9:00 am
RNS
Blocklisting Application
13 Dec 2019 4:48 pm
RNS
Director/PDMR Shareholding
11 Dec 2019 4:57 pm
RNS
Director/PDMR Shareholding
05 Dec 2019 12:00 pm
RNS
ViiV submits NDA to FDA for fostemsavir
04 Dec 2019 5:34 pm
RNS
Emma Walmsley - External Appointment
02 Dec 2019 5:52 pm
RNS
Director/PDMR Shareholding
  4:54 pm
RNS
Total Voting Rights
26 Nov 2019 3:00 pm
RNS
Block listing Interim Review
12 Nov 2019 3:51 pm
RNS
Director/PDMR Shareholding
08 Nov 2019 4:22 pm
RNS
Director/PDMR Shareholding
06 Nov 2019 4:36 pm
RNS
Director/PDMR Shareholding
04 Nov 2019 5:35 pm
RNS
Director/PDMR Shareholding
01 Nov 2019 5:19 pm
RNS
Director/PDMR Shareholding
  9:53 am
RNS
Total Voting Rights
31 Oct 2019 1:34 pm
RNS
Director/PDMR Shareholding
30 Oct 2019 5:32 pm
RNS
Director/PDMR Shareholding
  12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
  12:00 pm
RNS
3rd Quarter Results
21 Oct 2019 8:00 am
RNS
GSK divests two travel vaccines to Bavarian Nordic
15 Oct 2019 5:00 pm
RNS
Director/PDMR Shareholding
  5:00 pm
RNS
Director/PDMR Shareholding
  5:00 pm
RNS
Director/PDMR Shareholding
  5:00 pm
RNS
Director/PDMR Shareholding
11 Oct 2019 5:34 pm
RNS
Director/PDMR Shareholding
  4:10 pm
RNS
Director/PDMR Shareholding
10 Oct 2019 4:18 pm
RNS
Director/PDMR Shareholding
01 Oct 2019 6:18 pm
RNS
Director/PDMR Shareholding
  1:09 pm
RNS
Total Voting Rights
30 Sep 2019 7:00 am
RNS
Data show anti-tumour activity with ICOS agonist
  7:00 am
RNS
PRIMA shows Zejula improves PFS in ovarian cancer
26 Sep 2019 6:26 pm
RNS
Director/PDMR Shareholding
17 Sep 2019 5:46 pm
RNS
Director/PDMR Shareholding
11 Sep 2019 4:30 pm
RNS
Director/PDMR Shareholding
04 Sep 2019 5:37 pm
RNS
Director/PDMR Shareholding
  12:36 pm
RNS
Director/PDMR Shareholding
  9:33 am
RNS
Director/PDMR Shareholding
02 Sep 2019 11:29 am
RNS
Total Voting Rights
23 Aug 2019 7:00 am
RNS
GSK - positive results from pivotal DREAMM-2 study
22 Aug 2019 7:00 am
RNS
ViiV results positive for every 2 month injection
21 Aug 2019 8:00 am
RNS
GSK submits regulatory file in Japan: Daprodustat
12 Aug 2019 3:45 pm
RNS
Director/PDMR Shareholding
01 Aug 2019 3:30 pm
RNS
EU approval for Nucala self-administration
  2:10 pm
RNS
Total Voting Rights
  7:00 am
RNS
GSK completes transaction with Pfizer for New JV
30 Jul 2019 3:35 pm
RNS
Director/PDMR Shareholding
29 Jul 2019 7:00 am
RNS
ViiV submits cabotegravir to EMA for HIV injection
24 Jul 2019 6:01 pm
RNS
Director/PDMR Shareholding
  4:01 pm
RNS
ViiV 2DR TANGO switch study positive at 48 weeks
  4:00 pm
RNS
ViiV GEMINI studies show high efficacy at 96 weeks
  12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
  12:00 pm
RNS
2nd Quarter Results
  10:00 am
RNS
Non-Executive Chairman
22 Jul 2019 5:00 pm
RNS
ViiV presents 96-week data from phase III study
15 Jul 2019 6:19 pm
RNS
Director/PDMR Shareholding
  6:18 pm
RNS
Director/PDMR Shareholding
  6:16 pm
RNS
Director/PDMR Shareholding
  11:42 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
positive results in Phase 3 PRIMA study of ZEJULA
12 Jul 2019 4:35 pm
RNS
Director/PDMR Shareholding
  3:55 pm
RNS
Director/PDMR Shareholding
10 Jul 2019 3:48 pm
RNS
Director/PDMR Shareholding
  7:00 am
RNS
ViiV switch study shows 2DR as effective as 3DR
03 Jul 2019 9:00 am
RNS
ViiV receives Dovato EU Marketing Authorisation
01 Jul 2019 12:08 pm
RNS
Total Voting Rights
12 Jun 2019 5:10 pm
RNS
Director/PDMR Shareholding
07 Jun 2019 7:00 am
RNS
FDA approval for Nucala self-administration
04 Jun 2019 8:00 am
RNS
CHMP positive on GSK's Nucala self-administration
03 Jun 2019 2:31 pm
RNS
Total Voting Rights
24 May 2019 10:54 am
RNS
Director/PDMR Shareholding
20 May 2019 1:44 pm
RNS
Director/PDMR Shareholding
13 May 2019 5:44 pm
RNS
Block listing Interim Review
  4:19 pm
RNS
Director/PDMR Shareholding
08 May 2019 6:23 pm
RNS
Result of AGM & GM
02 May 2019 5:07 pm
RNS
Trelegy Ellipta asthma study met primary endpoint
01 May 2019 3:11 pm
RNS
Director/PDMR Shareholding
  2:32 pm
RNS
Total Voting Rights
  12:00 pm
RNS
1st Quarter Results
29 Apr 2019 12:00 pm
RNS
ViiV submits NDA for HIV monthly 2 drug injectable
26 Apr 2019 4:16 pm
RNS
ViiV receives CHMP Positive Opinion for Dovato
16 Apr 2019 5:36 pm
RNS
Director/PDMR Shareholding
  5:35 pm
RNS
Director/PDMR Shareholding
  5:23 pm
RNS
Director/PDMR Shareholding
  5:14 pm
RNS
Director/PDMR Shareholding
15 Apr 2019 2:45 pm
RNS
Director/PDMR Shareholding
12 Apr 2019 4:47 pm
RNS
Director/PDMR Shareholding
  4:33 pm
RNS
Director/PDMR Shareholding
11 Apr 2019 5:01 pm
RNS
Director/PDMR Shareholding
09 Apr 2019 7:00 am
RNS
FDA approves ViiV's two-drug HIV regimen, Dovato
02 Apr 2019 1:00 pm
RNS
Publication of AGM and GM Shareholder Documents
01 Apr 2019 4:36 pm
RNS
Total Voting Rights
28 Mar 2019 4:15 pm
RNS
GSK reporting changes - product sales and IFRS 16
25 Mar 2019 5:02 pm
RNS
Director/PDMR Shareholding
21 Mar 2019 4:00 pm
RNS
GSK announces further positive data from DREAMM-1
19 Mar 2019 5:45 pm
RNS
Data from GARNET study evaluating dostarlimab
18 Mar 2019 7:00 am
RNS
GSK Annual Report 2018 on Form 20-F
12 Mar 2019 3:19 pm
RNS
Director/PDMR Shareholding
  1:00 pm
RNS
Annual Financial Report
11 Mar 2019 6:24 pm
RNS
Director/PDMR Shareholding
08 Mar 2019 7:00 am
RNS
ViiV positive ph3 data for long acting injectable
05 Mar 2019 5:20 pm
RNS
Director/PDMR Shareholding
01 Mar 2019 10:10 am
RNS
Total Voting Rights
22 Feb 2019 5:30 pm
RNS
Director/PDMR Shareholding
  11:21 am
RNS
GSK response to SFO Statement
21 Feb 2019 4:37 pm
RNS
Director/PDMR Shareholding
  4:15 pm
RNS
Director/PDMR Shareholding
20 Feb 2019 2:44 pm
RNS
Director/PDMR Shareholding
19 Feb 2019 2:26 pm
RNS
Director/PDMR Shareholding
  1:53 pm
RNS
Director/PDMR Shareholding Replacement
18 Feb 2019 5:13 pm
RNS
Director/PDMR Shareholding
  4:14 pm
RNS
Director/PDMR Shareholding
15 Feb 2019 6:19 pm
RNS
Director/PDMR Shareholding
  6:16 pm
RNS
Director/PDMR Shareholding
  5:39 pm
RNS
Director/PDMR Shareholding
14 Feb 2019 10:33 am
RNS
Director/PDMR Shareholding
12 Feb 2019 2:05 pm
RNS
Director/PDMR Shareholding
  2:03 pm
RNS
Director/PDMR Shareholding
11 Feb 2019 12:42 pm
RNS
Director/PDMR Shareholding
  12:40 pm
RNS
Director/PDMR Shareholding
  12:38 pm
RNS
Director/PDMR Shareholding
  12:02 pm
RNS
Director/PDMR Shareholding
  12:01 pm
RNS
Director/PDMR Shareholding
08 Feb 2019 12:17 pm
RNS
Director/PDMR Shareholding
  12:16 pm
RNS
Director/PDMR Shareholding
06 Feb 2019 12:20 pm
RNS
Director/PDMR Shareholding
  12:01 pm
RNS
Final Results
05 Feb 2019 11:58 am
RNS
GSK and Merck announce global alliance for M7824
01 Feb 2019 3:45 pm
RNS
Total Voting Rights
23 Jan 2019 1:10 pm
RNS
Director/PDMR Shareholding
22 Jan 2019 1:56 pm
RNS
GSK completes acquisition of TESARO
21 Jan 2019 7:00 am
RNS
GSK Chairman succession process
15 Jan 2019 5:15 pm
RNS
Director/PDMR Shareholding
  4:09 pm
RNS
Director/PDMR Shareholding
  3:01 pm
RNS
Director/PDMR Shareholding
  2:59 pm
RNS
Director/PDMR Shareholding
  2:56 pm
RNS
Director/PDMR Shareholding
  2:47 pm
RNS
Director/PDMR Shareholding
  12:00 pm
RNS
GlaxoSmithKline Extends Tender Offer for TESARO
11 Jan 2019 4:32 pm
RNS
Director/PDMR Shareholding
  4:25 pm
RNS
Director/PDMR Shareholding
02 Jan 2019 1:45 pm
RNS
Total Voting Rights
20 Dec 2018 5:15 pm
RNS
Director/PDMR Shareholding
19 Dec 2018 7:00 am
RNS
GSK and Pfizer create new Consumer Healthcare JV
14 Dec 2018 1:20 pm
RNS
GSK Commences Tender Offer for TESARO Inc.
12 Dec 2018 4:35 pm
RNS
Director/PDMR Shareholding
04 Dec 2018 10:07 am
RNS
Director/PDMR Shareholding
03 Dec 2018 2:00 pm
RNS
Total Voting Rights
  12:02 pm
RNS
GSK reaches agreement to acquire TESARO
  8:35 am
RNS
GSK to divest Horlicks to Unilever
30 Nov 2018 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
29 Nov 2018 3:40 pm
RNS
Director/PDMR Shareholding
  11:45 am
RNS
GSK - Update on Review of Horlicks
27 Nov 2018 3:25 pm
RNS
Block listing Interim Review
22 Nov 2018 1:02 pm
RNS
GSK publishes 2019 Dividend Dates
12 Nov 2018 2:45 pm
RNS
Director/PDMR Shareholding
  9:00 am
RNS
Blocklisting Application
08 Nov 2018 12:43 pm
RNS
Director Declaration
02 Nov 2018 4:15 pm
RNS
Director/PDMR Shareholding
01 Nov 2018 1:40 pm
RNS
Total Voting Rights
31 Oct 2018 2:15 pm
RNS
ViiV positive phIII results with fostemsavir
  12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
  12:00 pm
RNS
3rd Quarter Results
30 Oct 2018 2:30 pm
RNS
ViiV: positive data for long-acting injectable
29 Oct 2018 10:00 am
RNS
ViiV - three-year data for long-acting injectable
18 Oct 2018 4:00 pm
RNS
ViiV submits HIV 2DR regulatory application to FDA
  9:34 am
RNS
Director/PDMR Shareholding
17 Oct 2018 5:56 pm
RNS
Director/PDMR Shareholding
  5:50 pm
RNS
Director/PDMR Shareholding
  11:30 am
RNS
Director/PDMR Shareholding
16 Oct 2018 4:53 pm
RNS
Director/PDMR Shareholding
  9:30 am
RNS
Director/PDMR Shareholding
  9:30 am
RNS
Director/PDMR Shareholding
10 Oct 2018 3:30 pm
RNS
Director/PDMR Shareholding
01 Oct 2018 1:58 pm
RNS
Total Voting Rights
27 Sep 2018 4:35 pm
RNS
Director/PDMR Shareholding
21 Sep 2018 12:30 pm
RNS
CHMP recommends expansion of Trelegy COPD label
14 Sep 2018 9:00 am
RNS
ViiV submits HIV 2DR regulatory application to EMA
12 Sep 2018 5:43 pm
RNS
Director/PDMR Shareholding
10 Sep 2018 8:00 am
RNS
New analysis on efficacy of anti-IL5 biologics SEA
  7:00 am
RNS
GSK receives CRL from FDA for mepolizumab in COPD
07 Sep 2018 2:24 pm
RNS
Director/PDMR Shareholding
  2:18 pm
RNS
Director/PDMR Shareholding
03 Sep 2018 5:00 pm
RNS
Total Voting Rights
30 Aug 2018 5:12 pm
RNS
GSK publishes Q4 2018 Dividend Dates
  8:12 am
RNS
EU approve Nucala in severe asthma in children
24 Aug 2018 10:16 am
RNS
Director/PDMR Shareholding
15 Aug 2018 7:00 am
RNS
Positive headline results for ViiV HC ATLAS study
10 Aug 2018 3:00 pm
RNS
Director/PDMR Shareholding
08 Aug 2018 12:35 pm
RNS
Director/PDMR Shareholding
07 Aug 2018 7:00 am
RNS
Iain Mackay appointed GSK Chief Financial Officer
02 Aug 2018 5:07 pm
RNS
Publication of Base Prospectus
  11:04 am
RNS
Total Voting Rights
31 Jul 2018 5:03 pm
RNS
Director/PDMR Shareholding
  4:37 pm
RNS
Director/PDMR Shareholding
27 Jul 2018 4:30 pm
RNS
Director/PDMR Shareholding
  2:47 pm
RNS
CHMP recommend Nucala for severe asthma children
26 Jul 2018 7:00 am
RNS
GSK reports on FDA Ad Com on mepolizumab for COPD
25 Jul 2018 4:15 pm
RNS
Director/PDMR Shareholding
  11:00 am
RNS
GSK and 23andMe Agreement
  11:00 am
RNS
2nd Quarter Results
24 Jul 2018 9:00 am
RNS
ViiV shows positive phIII data on two-drug combo
19 Jul 2018 4:45 pm
RNS
Director/PDMR Shareholding
17 Jul 2018 5:46 pm
RNS
Director/PDMR Shareholding
  4:54 pm
RNS
Director/PDMR Shareholding
  4:49 pm
RNS
Director/PDMR Shareholding
16 Jul 2018 2:51 pm
RNS
Director/PDMR Shareholding
  11:11 am
RNS
Director/PDMR Shareholding
13 Jul 2018 4:16 pm
RNS
Director/PDMR Shareholding
  4:16 pm
RNS
Director/PDMR Shareholding
11 Jul 2018 2:42 pm
RNS
Director/PDMR Shareholding
02 Jul 2018 2:30 pm
RNS
Total Voting Rights
14 Jun 2018 7:00 am
RNS
Positive headline results for ViiV GEMINI studies
12 Jun 2018 5:15 pm
RNS
Director/PDMR Shareholding
  2:00 pm
RNS
GSK announces changes to Corporate Executive Team
01 Jun 2018 1:00 pm
RNS
GSK completes Consumer Healthcare buyout
  9:42 am
RNS
Total Voting Rights
29 May 2018 7:00 am
RNS
GSK Once-daily single inhaler triple therapy COPD
21 May 2018 11:02 am
RNS
ViiV granted EU marketing authorisation for Juluca
15 May 2018 1:39 pm
RNS
Director/PDMR Shareholding
11 May 2018 3:17 pm
RNS
Director/PDMR Shareholding
10 May 2018 5:20 pm
RNS
Block listing Interim Review
09 May 2018 5:05 pm
RNS
Director/PDMR Shareholding - replacement
  12:00 pm
RNS
Directorate Change
03 May 2018 6:31 pm
RNS
Result of General Meeting
  6:29 pm
RNS
Result of AGM
01 May 2018 2:45 pm
RNS
Total Voting Rights
27 Apr 2018 12:43 pm
RNS
Director/PDMR Shareholding
26 Apr 2018 3:30 pm
RNS
Director/PDMR Shareholding
25 Apr 2018 12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
  12:00 pm
RNS
1st Quarter Results
24 Apr 2018 5:41 pm
RNS
Trelegy Ellipta expanded US COPD indication
20 Apr 2018 3:15 pm
RNS
Director/PDMR Shareholding
  3:15 pm
RNS
Director/PDMR Shareholding
19 Apr 2018 7:00 am
RNS
IMPACT study shows benefits of Trelegy Ellipta
18 Apr 2018 10:34 am
RNS
Landmark IMPACT study to be published in NEJM
17 Apr 2018 1:47 pm
RNS
Director/PDMR Shareholding
  1:36 pm
RNS
Director/PDMR Shareholding
  1:30 pm
RNS
Director/PDMR Shareholding
  1:24 pm
RNS
Director/PDMR Shareholding
  1:20 pm
RNS
Director/PDMR Shareholding
13 Apr 2018 3:50 pm
RNS
Director/PDMR Shareholding
  3:44 pm
RNS
Director/PDMR Shareholding
  11:32 am
RNS
Notice of GM
12 Apr 2018 3:04 pm
RNS
Director/PDMR Shareholding
03 Apr 2018 4:14 pm
RNS
Total Voting Rights
29 Mar 2018 1:00 pm
RNS
Notice of AGM
27 Mar 2018 7:00 am
RNS
GSK agrees to acquire CH business from Novartis
23 Mar 2018 11:21 am
RNS
ViiV - CHMP positive opinion for Juluca in Europe
  7:44 am
RNS
Update regarding Pfizer Inc. Consumer Healthcare
  7:00 am
RNS
Shingrix approved in Europe and Japan
19 Mar 2018 7:00 am
RNS
GSK 2017 Form 20-F
13 Mar 2018 2:10 pm
RNS
Annual Financial Report
12 Mar 2018 4:30 pm
RNS
Director/PDMR Shareholding
08 Mar 2018 8:00 am
RNS
GSK announces labelling update to Relvar Ellipta
05 Mar 2018 5:01 pm
RNS
ViiV Healthcare announces new dolutegravir data
  2:47 pm
RNS
Nucala OSMO study presented at AAAAI-WAO congress
  12:04 pm
RNS
Director/PDMR Shareholding
02 Mar 2018 1:11 pm
RNS
Director/PDMR Shareholding
01 Mar 2018 11:16 am
RNS
Total Voting Rights
22 Feb 2018 4:54 pm
RNS
Director/PDMR Shareholding
20 Feb 2018 1:17 pm
RNS
Director/PDMR Shareholding
  1:16 pm
RNS
Director/PDMR Shareholding
  1:15 pm
RNS
Director/PDMR Shareholding
19 Feb 2018 6:12 pm
RNS
Director/PDMR Shareholding
16 Feb 2018 5:29 pm
RNS
Director/PDMR Shareholding
  5:25 pm
RNS
Director/PDMR Shareholding
  11:20 am
RNS
Director/PDMR Shareholding
15 Feb 2018 6:09 pm
RNS
Director/PDMR Shareholding
  5:57 pm
RNS
Director/PDMR Shareholding
  5:53 pm
RNS
Director/PDMR Shareholding
14 Feb 2018 9:00 am
RNS
GSK submits landmark IMPACT data - Trelegy Ellipta
13 Feb 2018 4:44 pm
RNS
Director/PDMR Shareholding
12 Feb 2018 2:43 pm
RNS
Director/PDMR Shareholding
  12:47 pm
RNS
Director/PDMR Shareholding
08 Feb 2018 9:31 am
RNS
ViiV Healthcare launches new two-drug HIV study
  7:00 am
RNS
ViiV files patent infringement litigation
07 Feb 2018 1:19 pm
RNS
Director/PDMR Shareholding
  12:01 pm
RNS
Final Results
  9:04 am
RNS
GSK's Bexsero FDA Breakthrough Therapy Designation
01 Feb 2018 11:52 am
RNS
Total Voting Rights
26 Jan 2018 12:30 pm
RNS
GSK's Shingrix - positive CHMP opinion in Europe
  9:00 am
RNS
GSK's Relvar Ellipta - positive CHMP opinion
23 Jan 2018 3:22 pm
RNS
Director/PDMR Shareholding
19 Jan 2018 5:19 pm
RNS
Director/PDMR Shareholding
  5:17 pm
RNS
Director/PDMR Shareholding
16 Jan 2018 5:48 pm
RNS
Director/PDMR Shareholding
15 Jan 2018 5:59 pm
RNS
Director/PDMR Shareholding
  5:54 pm
RNS
Director/PDMR Shareholding
  5:34 pm
RNS
Director/PDMR Shareholding
  9:18 am
RNS
Director/PDMR Shareholding
  9:04 am
RNS
Director/PDMR Shareholding
11 Jan 2018 3:33 pm
RNS
Director/PDMR Shareholding
02 Jan 2018 2:00 pm
RNS
Director Shareholding
  1:54 pm
RNS
Total Voting Rights
21 Dec 2017 9:02 am
RNS
FDA approval - on ICS/LABA combinations in asthma
18 Dec 2017 4:21 pm
RNS
Director/PDMR Shareholding
15 Dec 2017 7:00 am
RNS
Transfer of Shares out of Treasury
12 Dec 2017 4:50 pm
RNS
Director/PDMR Shareholding
  4:16 pm
RNS
GSK gains US approval for Nucala to treat EGPA
  7:00 am
RNS
Promising data for GSK2857916 at ASH meeting
06 Dec 2017 7:00 am
RNS
New data - Shingrix in immune-compromised patients
01 Dec 2017 1:47 pm
RNS
Director/PDMR Shareholding
  1:44 pm
RNS
Director/PDMR Shareholding
  1:37 pm
RNS
Total Voting Rights
30 Nov 2017 7:00 am
RNS
ViiV starts Phase 3 HIV prevention study in women
27 Nov 2017 2:03 pm
RNS
ViiV starts Phase 3 longacting HIV treatment study
23 Nov 2017 7:00 am
RNS
GSK submit IMPACT data to support Trelegy Ellipta
22 Nov 2017 7:00 am
RNS
ViiV Juluca approved in US as first 2-drug regimen
21 Nov 2017 2:21 pm
RNS
GSK publishes 2018 dividend dates
16 Nov 2017 7:00 am
RNS
Trelegy Ellipta EU approval for treatment of COPD
10 Nov 2017 1:15 pm
RNS
Director/PDMR Shareholding
09 Nov 2017 5:00 pm
RNS
Block listing Interim Review
08 Nov 2017 2:00 pm
RNS
Directorate Change
  2:00 pm
RNS
Directorate Change
07 Nov 2017 3:01 pm
RNS
US regulatory application for mepolizumab in COPD
02 Nov 2017 7:35 am
RNS
BCMA receives FDA Breakthrough Therapy Designation
01 Nov 2017 12:01 pm
RNS
Total Voting Rights
  11:01 am
RNS
Superiority of Anoro Ellipta demonstrated for COPD
25 Oct 2017 5:46 pm
RNS
CDC ACIP makes recommendations for use of Shingrix
  3:21 pm
RNS
Director/PDMR Shareholding
  12:00 pm
RNS
3rd Quarter Results
23 Oct 2017 7:00 am
RNS
GSK's Shingrix Receives US FDA Approval
20 Oct 2017 4:12 pm
RNS
Director/PDMR Shareholding
  4:08 pm
RNS
Director/PDMR Shareholding
16 Oct 2017 4:52 pm
RNS
Director/PDMR Shareholding
  4:42 pm
RNS
Director/PDMR Shareholding
  4:40 pm
RNS
Director/PDMR Shareholding
  4:40 pm
RNS
Director/PDMR Shareholding
  11:02 am
RNS
Director/PDMR Shareholding
  10:57 am
RNS
Director/PDMR Shareholding
13 Oct 2017 6:31 pm
RNS
GSK first approval of Shingrix in Canada
  4:25 pm
RNS
Director/PDMR Shareholding
  4:20 pm
RNS
Director/PDMR Shareholding
  11:53 am
RNS
Director/PDMR Shareholding
11 Oct 2017 1:34 pm
RNS
Director/PDMR Shareholding
02 Oct 2017 10:19 am
RNS
Total Voting Rights
25 Sep 2017 2:57 pm
RNS
Director/PDMR Shareholding
20 Sep 2017 7:00 am
RNS
Positive IMPACT results for Trelegy in COPD
19 Sep 2017 7:00 am
RNS
Trelegy Ellipta: FDA approval in COPD received
15 Sep 2017 7:00 am
RNS
Trelegy Ellipta: positive opinion from CHMP Europe
14 Sep 2017 7:00 am
RNS
Unanimous FDA approval for Shingrix in over 50s
12 Sep 2017 4:07 pm
RNS
Director/PDMR Shareholding
  8:57 am
RNS
GSK: phase III results on mepo in COPD in NEJM
11 Sep 2017 8:08 am
RNS
GSK announce positive results from SLS lung study
06 Sep 2017 4:02 pm
RNS
Director/PDMR Shareholding
01 Sep 2017 9:43 am
RNS
Total Voting Rights
10 Aug 2017 4:43 pm
RNS
Director/PDMR Shareholding
  10:50 am
RNS
Director/PDMR Shareholding
04 Aug 2017 9:06 am
RNS
Base prospectus re �15bn EMTN programme
01 Aug 2017 11:02 am
RNS
Total Voting Rights
28 Jul 2017 4:03 pm
RNS
Director/PDMR Shareholding
  3:51 pm
RNS
Director/PDMR Shareholding
26 Jul 2017 1:22 pm
RNS
Director/PDMR Shareholding
  12:41 pm
RNS
Director/PDMR Shareholding - Replacement
  11:00 am
RNS
Half-year Report
25 Jul 2017 1:30 pm
RNS
ViiV announces results from NEAT 022 study
  1:30 pm
RNS
ViiV announces positive results from DAWNING
24 Jul 2017 9:02 am
RNS
LATTE-2 phII results presented at IAS in Paris
21 Jul 2017 3:34 pm
RNS
Director/PDMR Shareholding
  3:30 pm
RNS
Director/PDMR Shareholding
  1:59 pm
RNS
GSK submits EU filing for Relvar Ellipta extension
  11:00 am
RNS
Directorate Change
17 Jul 2017 6:08 pm
RNS
Director/PDMR Shareholding
  5:44 pm
RNS
Director/PDMR Shareholding
  5:37 pm
RNS
Director/PDMR Shareholding
  5:19 pm
RNS
Director/PDMR Shareholding
  4:53 pm
RNS
Director/PDMR Shareholding
  4:37 pm
RNS
Director/PDMR Shareholding
  2:20 pm
RNS
Director/PDMR Shareholding
14 Jul 2017 4:58 pm
RNS
Director/PDMR Shareholding
  4:46 pm
RNS
Director/PDMR Shareholding
  4:02 pm
RNS
Director/PDMR Shareholding
  11:57 am
RNS
Director/PDMR Shareholding
12 Jul 2017 4:12 pm
RNS
Director/PDMR Shareholding
03 Jul 2017 10:05 am
RNS
Total Voting Rights
28 Jun 2017 4:13 pm
RNS
GSK announces US filing for mepo in EGPA
27 Jun 2017 10:06 am
RNS
GSK starts phIII study on mepo for nasal polyps
21 Jun 2017 2:35 pm
RNS
Director/PDMR Shareholding
  2:05 pm
RNS
GSK presents Shingrix PhIII study results at ACIP
19 Jun 2017 4:29 pm
RNS
GSK confirms start date for Luke Miels
12 Jun 2017 4:43 pm
RNS
Director/PDMR Shareholding
05 Jun 2017 5:23 pm
RNS
Director/PDMR Shareholding
02 Jun 2017 7:00 am
RNS
ViiV submits first 2-drug HIV regimen application
01 Jun 2017 10:58 am
RNS
Total Voting Rights
31 May 2017 4:25 pm
RNS
Director/PDMR Shareholding
22 May 2017 4:45 pm
RNS
Director/PDMR Shareholding
  4:40 pm
RNS
Director/PDMR Shareholding
  2:23 pm
RNS
Ph3 MUSCA study presented at ATS
18 May 2017 7:00 am
RNS
NEJM publication of PH3 study into Mepo in EGPA
12 May 2017 4:26 pm
RNS
Block listing Interim Review
11 May 2017 5:29 pm
RNS
Director/PDMR Shareholding
10 May 2017 4:26 pm
RNS
Headline Phase III results: Mepo in COPD
05 May 2017 12:39 pm
RNS
Rellvar Ellipta 2nd Salford Lung Study Results
04 May 2017 6:10 pm
RNS
Result of AGM
02 May 2017 1:02 pm
RNS
Director/PDMR Shareholding
  10:02 am
RNS
Total Voting Rights
27 Apr 2017 5:40 pm
RNS
Director/PDMR Shareholding
  4:53 pm
RNS
Companies Act 2006 s430 (2B) Disclosure
26 Apr 2017 5:25 pm
RNS
Indenture 2004 - change of trustee
  12:00 pm
RNS
1st Quarter Results
25 Apr 2017 5:24 pm
RNS
Director/PDMR Shareholding
  1:45 pm
RNS
Director/PDMR Shareholding
24 Apr 2017 4:52 pm
RNS
Director/PDMR Shareholding replacement
21 Apr 2017 2:49 pm
RNS
Director/PDMR Shareholding
  1:36 pm
RNS
Director/PDMR Shareholding
19 Apr 2017 5:38 pm
RNS
Director/PDMR Shareholding
  4:34 pm
RNS
Director/PDMR Shareholding
  4:27 pm
RNS
Director/PDMR Shareholding
  4:14 pm
RNS
Director/PDMR Shareholding
  4:04 pm
RNS
Director/PDMR Shareholding
  1:32 pm
RNS
Director/PDMR Shareholding
  1:27 pm
RNS
Director/PDMR Shareholding
  1:21 pm
RNS
Director/PDMR Shareholding
18 Apr 2017 4:13 pm
RNS
Director/PDMR Shareholding
  9:16 am
RNS
GSK vaccine submission for shingles in Japan
11 Apr 2017 5:26 pm
RNS
Director/PDMR Shareholding
  12:02 pm
RNS
Change to financial reporting framework
03 Apr 2017 11:26 am
RNS
Total Voting Rights
31 Mar 2017 11:04 am
RNS
Phase 3 study start of mepolizumab in severe HES
30 Mar 2017 1:00 pm
RNS
Notice of AGM
23 Mar 2017 4:55 pm
RNS
Director/PDMR Shareholding
21 Mar 2017 12:19 pm
RNS
Director/PDMR Shareholding
20 Mar 2017 7:00 am
RNS
GSK 2016 Form 20F
16 Mar 2017 4:13 pm
RNS
Director/PDMR Shareholding
15 Mar 2017 5:07 pm
RNS
Director/PDMR Shareholding
14 Mar 2017 1:00 pm
RNS
Publication of 2016 Annual Financial Report
10 Mar 2017 4:10 pm
RNS
Director/PDMR Shareholding
08 Mar 2017 4:26 pm
RNS
Director/PDMR Shareholding
06 Mar 2017 4:51 pm
RNS
Director/PDMR Shareholding
  2:49 pm
RNS
GSK's MUSCA study results on Nucala (mepolizumab)
01 Mar 2017 10:06 am
RNS
Total Voting Rights
23 Feb 2017 3:07 pm
RNS
Director/PDMR Shareholding
  2:57 pm
RNS
Director/PDMR Shareholding
  9:59 am
RNS
Positive results for Relvar Ellipta Lung Study
22 Feb 2017 1:58 pm
RNS
Director/PDMR Shareholding
21 Feb 2017 5:14 pm
RNS
Director/PDMR Shareholding
20 Feb 2017 3:55 pm
RNS
Director/PDMR Shareholding
  2:12 pm
RNS
Director/PDMR Shareholding
17 Feb 2017 3:58 pm
RNS
Director/PDMR Shareholding
  3:57 pm
RNS
Director/PDMR Shareholding
  3:55 pm
RNS
Director/PDMR Shareholding
15 Feb 2017 5:15 pm
RNS
Director/PDMR Shareholding
14 Feb 2017 12:43 pm
RNS
Director/PDMR Shareholding
  9:49 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
ViiV Phase III results Dolutegravir & Rilpivirine
13 Feb 2017 5:04 pm
RNS
Director/PDMR Shareholding
10 Feb 2017 3:47 pm
RNS
Director/PDMR Shareholding
  11:10 am
RNS
Director/PDMR Shareholding
  8:42 am
RNS
Blocklisting Application
09 Feb 2017 5:32 pm
RNS
Director/PDMR Shareholding
  1:42 pm
RNS
Director/PDMR Shareholding
08 Feb 2017 5:27 pm
RNS
Director/PDMR Shareholding
  12:00 pm
RNS
Final Results
01 Feb 2017 11:02 am
RNS
Total Voting Rights
25 Jan 2017 4:17 pm
RNS
Director/PDMR Shareholding
24 Jan 2017 4:51 pm
RNS
Director/PDMR Shareholding
23 Jan 2017 3:45 pm
RNS
Director/PDMR Shareholding
20 Jan 2017 3:07 pm
RNS
Director/PDMR Shareholding
19 Jan 2017 7:05 am
RNS
Corporate executive team changes
  7:00 am
RNS
Corporate executive team changes
16 Jan 2017 6:25 pm
RNS
Director/PDMR Shareholding
  6:08 pm
RNS
Director/PDMR Shareholding
  5:15 pm
RNS
Director/PDMR Shareholding
  5:04 pm
RNS
Director/PDMR Shareholding
  4:54 pm
RNS
Director/PDMR Shareholding
  4:01 pm
RNS
Director/PDMR Shareholding
  3:51 pm
RNS
Director/PDMR Shareholding
13 Jan 2017 4:40 pm
RNS
Director/PDMR Shareholding
  3:44 pm
RNS
Director/PDMR Shareholding
  2:29 pm
RNS
Director/PDMR Shareholding
12 Jan 2017 4:38 pm
RNS
Director/PDMR Shareholding
10 Jan 2017 4:51 pm
RNS
Director/PDMR Shareholding
03 Jan 2017 10:34 am
RNS
Total Voting Rights
20 Dec 2016 2:03 pm
RNS
ViiV starts HIV prevention study with cabotegravir
  7:17 am
RNS
Blocklisting Application
  7:00 am
RNS
ViiV announce phase III results for 2-drug regimen
19 Dec 2016 3:19 pm
RNS
Directorate Change
  9:32 am
RNS
Phase III study start for closed triple in asthma
16 Dec 2016 5:32 pm
RNS
Treasury Stock
  10:45 am
RNS
Director/PDMR Shareholding
13 Dec 2016 9:11 am
RNS
Audit Tender Conclusion
12 Dec 2016 3:56 pm
RNS
Director/PDMR Shareholding
02 Dec 2016 3:49 pm
RNS
Director/PDMR Shareholding
  2:19 pm
RNS
GSK files closed triple therapy for COPD in EU
  7:01 am
RNS
Relvar Ellipta approved in Japan for COPD
01 Dec 2016 11:00 am
RNS
Total Voting Rights
30 Nov 2016 4:52 pm
RNS
Director/PDMR Shareholding
25 Nov 2016 1:35 pm
RNS
EU submission of shingles candidate vaccine
24 Nov 2016 11:07 am
RNS
Start of Phase III studies with daprodustat
23 Nov 2016 7:05 am
RNS
Mepolizumab meets endpoints in phase 3 EGPA study
21 Nov 2016 7:02 am
RNS
GSK files closed triple therapy for COPD in US
18 Nov 2016 2:40 pm
RNS
ViiV starts PhIII LA injectable treatment regimen
16 Nov 2016 4:04 pm
RNS
New phase III data of sirukumab for RA
10 Nov 2016 3:09 pm
RNS
Director/PDMR Shareholding
08 Nov 2016 5:04 pm
RNS
Block listing Interim Review
  5:01 pm
RNS
Director/PDMR Shareholding
04 Nov 2016 5:12 pm
RNS
Director/PDMR Shareholding
02 Nov 2016 4:49 pm
RNS
Director/PDMR Shareholding
01 Nov 2016 10:21 am
RNS
Total Voting Rights
28 Oct 2016 2:17 pm
RNS
Director/PDMR Shareholding
27 Oct 2016 5:40 pm
RNS
Director/PDMR Shareholding
  12:06 pm
RNS
GSK issues new data on shingles candidate vaccine
26 Oct 2016 5:10 pm
RNS
Director/PDMR Shareholding
  3:41 pm
RNS
Director/PDMR Shareholding
  12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
  12:00 pm
RNS
3rd Quarter Results
25 Oct 2016 2:12 pm
RNS
Director/PDMR Shareholding
24 Oct 2016 7:00 am
RNS
US FDA submission of shingles candidate vaccine
21 Oct 2016 4:12 pm
RNS
Director/PDMR Shareholding
18 Oct 2016 7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
17 Oct 2016 6:28 pm
RNS
Director/PDMR Shareholding
  6:21 pm
RNS
Director/PDMR Shareholding
  6:17 pm
RNS
Director/PDMR Shareholding
14 Oct 2016 5:27 pm
RNS
Director/PDMR Shareholding
  5:13 pm
RNS
Director/PDMR Shareholding
  5:10 pm
RNS
Director/PDMR Shareholding
12 Oct 2016 5:27 pm
RNS
Director/PDMR Shareholding
10 Oct 2016 4:47 pm
RNS
Director/PDMR Shareholding
03 Oct 2016 10:03 am
RNS
Total Voting Rights
29 Sep 2016 10:17 am
RNS
Director/PDMR Shareholding
  7:54 am
RNS
GSK completes sale of holding in Aspen
28 Sep 2016 4:19 pm
RNS
GSK intends to sell remaining holding in Aspen
26 Sep 2016 5:02 pm
RNS
Director/PDMR Shareholding
  4:56 pm
RNS
Director/PDMR Shareholding
23 Sep 2016 1:00 pm
RNS
US Regulatory Submission for sirukumab in RA
20 Sep 2016 7:00 am
RNS
GSK Appoints New CEO
19 Sep 2016 3:13 pm
RNS
Director/PDMR Shareholding
15 Sep 2016 7:00 am
RNS
Results Phase III Study Shingrix Vaccine in NEJM
12 Sep 2016 4:58 pm
RNS
Director/PDMR Shareholding
  12:33 pm
RNS
EU regulatory submission for sirukumab in RA
06 Sep 2016 2:49 pm
RNS
Results of Phase III FULFIL Study Presented at ERS
05 Sep 2016 7:00 am
RNS
Positive Results from the COPD Salford Lung Study
01 Sep 2016 2:42 pm
RNS
Total Voting Rights
30 Aug 2016 12:36 pm
RNS
Director/PDMR Shareholding
23 Aug 2016 3:45 pm
RNS
Director/PDMR Shareholding
16 Aug 2016 3:07 pm
RNS
Director/PDMR Shareholding
  1:07 pm
RNS
ViiV starts PhIII Programme for dolutegravir & 3TC
12 Aug 2016 4:08 pm
RNS
Director/PDMR Shareholding
10 Aug 2016 2:45 pm
RNS
Director/PDMR Shareholding
09 Aug 2016 5:43 pm
RNS
Director/PDMR Shareholding
04 Aug 2016 3:49 pm
RNS
Publication of a Prospectus
01 Aug 2016 3:26 pm
RNS
Director/PDMR Shareholding
  12:11 pm
RNS
Total Voting Rights
  7:00 am
RNS
GSK and Verily to establish Galvani Bioelectronics
28 Jul 2016 6:22 pm
RNS
Director/PDMR Shareholding
27 Jul 2016 12:01 pm
RNS
Half-year Report
25 Jul 2016 3:29 pm
RNS
Director/PDMR Shareholding
20 Jul 2016 5:15 pm
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
19 Jul 2016 6:31 pm
RNS
Director/PDMR Shareholding
  6:28 pm
RNS
Director/PDMR Shareholding
  6:25 pm
RNS
Director/PDMR Shareholding
  6:21 pm
RNS
Director/PDMR Shareholding
  5:57 pm
RNS
Director/PDMR Shareholding
  5:54 pm
RNS
Director/PDMR Shareholding
  5:50 pm
RNS
Director/PDMR Shareholding
  5:45 pm
RNS
Director/PDMR Shareholding
  5:39 pm
RNS
Director/PDMR Shareholding
  5:33 pm
RNS
Director/PDMR Shareholding
18 Jul 2016 5:05 pm
RNS
Director/PDMR Shareholding
  5:05 pm
RNS
Director/PDMR Shareholding
  5:00 pm
RNS
Director/PDMR Shareholding
  4:59 pm
RNS
Director/PDMR Shareholding
  4:58 pm
RNS
Director/PDMR Shareholding
  4:56 pm
RNS
Director/PDMR Shareholding
  4:50 pm
RNS
Director/PDMR Shareholding
  4:44 pm
RNS
Director/PDMR Shareholding
  4:41 pm
RNS
Director/PDMR Shareholding
  4:09 pm
RNS
Director/PDMR Shareholding
  4:06 pm
RNS
Director/PDMR Shareholding
  4:04 pm
RNS
Director/PDMR Shareholding
  3:54 pm
RNS
Director/PDMR Shareholding
  3:51 pm
RNS
Director/PDMR Shareholding
  3:49 pm
RNS
Director/PDMR Shareholding
  3:46 pm
RNS
Director/PDMR Shareholding
  3:42 pm
RNS
Director/PDMR Shareholding
  3:40 pm
RNS
Director/PDMR Shareholding
  3:35 pm
RNS
Director/PDMR Shareholding
  3:34 pm
RNS
Director/PDMR Shareholding
  3:26 pm
RNS
Director/PDMR Shareholding
  3:23 pm
RNS
Director/PDMR Shareholding
  2:55 pm
RNS
Director/PDMR Shareholding
  2:53 pm
RNS
Director/PDMR Shareholding
  2:49 pm
RNS
Director/PDMR Shareholding
  2:44 pm
RNS
Director/PDMR Shareholding
  2:41 pm
RNS
Director/PDMR Shareholding
  2:38 pm
RNS
Director/PDMR Shareholding
  12:05 pm
RNS
Director/PDMR Shareholding
  12:04 pm
RNS
Director/PDMR Shareholding
  11:59 am
RNS
Director/PDMR Shareholding
  11:57 am
RNS
Director/PDMR Shareholding
  11:54 am
RNS
Director/PDMR Shareholding
  11:51 am
RNS
Director/PDMR Shareholding
  11:49 am
RNS
Director/PDMR Shareholding
  11:47 am
RNS
Director/PDMR Shareholding
  11:45 am
RNS
Director/PDMR Shareholding
  11:44 am
RNS
Director/PDMR Shareholding
  11:25 am
RNS
Director/PDMR Shareholding
  10:02 am
RNS
Director/PDMR Shareholding
  9:58 am
RNS
Director/PDMR Shareholding
14 Jul 2016 12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
12 Jul 2016 5:56 pm
RNS
Director/PDMR Shareholding
  5:54 pm
RNS
Director/PDMR Shareholding
  5:51 pm
RNS
Director/PDMR Shareholding
  5:49 pm
RNS
Director/PDMR Shareholding
  5:47 pm
RNS
Director/PDMR Shareholding
  5:44 pm
RNS
Director/PDMR Shareholding
  5:44 pm
RNS
Director/PDMR Shareholding
  5:41 pm
RNS
Director/PDMR Shareholding
  5:37 pm
RNS
Director/PDMR Shareholding
  5:34 pm
RNS
Director/PDMR Shareholding
  5:32 pm
RNS
Director/PDMR Shareholding
  5:19 pm
RNS
Director/PDMR Shareholding
  5:10 pm
RNS
Director/PDMR Shareholding
01 Jul 2016 4:25 pm
RNS
Director/PDMR Shareholding
  11:32 am
RNS
Total Voting Rights
20 Jun 2016 7:02 am
RNS
FULFIL Study Results Closed Triple EU
14 Jun 2016 10:58 am
RNS
Directorate Change
10 Jun 2016 5:09 pm
RNS
Director/PDMR Shareholding
  4:48 pm
RNS
Director/PDMR Shareholding
08 Jun 2016 12:00 pm
RNS
Phase III Study of Sirukumab Results
02 Jun 2016 7:00 am
RNS
Closed Triple Combined FF-UMEC-VI US Filing Plans
01 Jun 2016 9:55 am
RNS
Total Voting Rights
27 May 2016 3:46 pm
RNS
Strimvelis receives EC marketing authorisation
  2:56 pm
RNS
Board and Committee changes
24 May 2016 10:54 am
RNS
Salford Lung Study Results
23 May 2016 3:47 pm
RNS
Director/PDMR Shareholding
13 May 2016 10:56 am
RNS
Director/PDMR Shareholding
12 May 2016 4:52 pm
RNS
Director/PDMR Shareholding
11 May 2016 11:48 am
RNS
Block listing Interim Review
10 May 2016 5:15 pm
RNS
Director/PDMR Shareholding
09 May 2016 1:05 pm
RNS
Director/PDMR Shareholding
06 May 2016 1:30 pm
RNS
Director/PDMR Shareholding
05 May 2016 5:41 pm
RNS
Result of AGM
04 May 2016 2:55 pm
RNS
Director/PDMR Shareholding
  2:51 pm
RNS
Director/PDMR Shareholding
  2:44 pm
RNS
Director/PDMR Shareholding
03 May 2016 2:36 pm
RNS
Director/PDMR Shareholding
  11:28 am
RNS
Director/PDMR Shareholding
  11:21 am
RNS
Total Voting Rights
29 Apr 2016 5:47 pm
RNS
Director/PDMR Shareholding
  5:43 pm
RNS
Director/PDMR Shareholding
  5:34 pm
RNS
Director/PDMR Shareholding
  5:29 pm
RNS
Director/PDMR Shareholding
  5:23 pm
RNS
Director/PDMR Shareholding
  5:19 pm
RNS
Director/PDMR Shareholding
  5:14 pm
RNS
Director/PDMR Shareholding
  5:09 pm
RNS
Director/PDMR Shareholding
28 Apr 2016 12:43 pm
RNS
Director/PDMR Shareholding
27 Apr 2016 12:00 pm
RNS
1st Quarter Results
18 Apr 2016 5:09 pm
RNS
Director/PDMR Shareholding
  4:23 pm
RNS
Director/PDMR Shareholding
  4:16 pm
RNS
Director/PDMR Shareholding
15 Apr 2016 4:26 pm
RNS
Director/PDMR Shareholding
12 Apr 2016 6:07 pm
RNS
Director/PDMR Shareholding
11 Apr 2016 4:28 pm
RNS
Director/PDMR Shareholding
01 Apr 2016 3:33 pm
RNS
Director/PDMR Shareholding
  3:19 pm
RNS
Director/PDMR Shareholding
  3:07 pm
RNS
GSK receives positive CHMP opinion for Strimvelis
  1:01 pm
RNS
Total Voting Rights
30 Mar 2016 5:48 pm
RNS
Director/PDMR Shareholding
  12:00 pm
RNS
Notice of AGM
29 Mar 2016 5:23 pm
RNS
Director/PDMR Shareholding
  7:01 am
RNS
Marketing approval received for Nucala? in Japan
22 Mar 2016 3:14 pm
RNS
Director/PDMR Shareholding
21 Mar 2016 4:09 pm
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Annual Report 2015 on Form 20-F
18 Mar 2016 2:58 pm
RNS
Director/PDMR Shareholding
17 Mar 2016 7:29 am
RNS
Vestri Study Results GSK Advair in Children 4-11
  7:00 am
RNS
Directorate Changes
  7:00 am
RNS
Sir Andrew Witty to retire from GSK in March 2017
  7:00 am
RNS
Publication of 2015 Annual Financial Report
11 Mar 2016 12:04 pm
RNS
Director/PDMR Shareholding
10 Mar 2016 2:40 pm
RNS
Director/PDMR Shareholding
07 Mar 2016 3:12 pm
RNS
Director/PDMR Shareholding
  7:00 am
RNS
NEJM results of LABA Safety Study of Advair Diskus
01 Mar 2016 4:43 pm
RNS
Director/PDMR Shareholding- Replacement
  2:43 pm
RNS
Director/PDMR Shareholding
  2:41 pm
RNS
Director/PDMR Shareholding
  2:41 pm
RNS
Director/PDMR Shareholding
  2:36 pm
RNS
Director/PDMR Shareholding
  2:33 pm
RNS
Director/PDMR Shareholding
  11:04 am
RNS
Total Voting Rights
25 Feb 2016 11:23 am
RNS
Director/PDMR Shareholding
24 Feb 2016 5:05 pm
RNS
PhII HIV prevention study results cabotegravir
23 Feb 2016 5:13 pm
RNS
PhII data on 2 drug long-acting injectable for HIV
22 Feb 2016 3:38 pm
RNS
ViiV completes transaction to acquire BMS Assets
18 Feb 2016 2:27 pm
RNS
Director/PDMR Shareholding
16 Feb 2016 5:22 pm
RNS
Director/PDMR Shareholding- Replacement
  5:20 pm
RNS
Director/PDMR Shareholding- Replacement
15 Feb 2016 5:58 pm
RNS
Director/PDMR Shareholding
  5:55 pm
RNS
Director/PDMR Shareholding
  10:55 am
RNS
Director/PDMR Shareholding
12 Feb 2016 4:21 pm
RNS
Director/PDMR Shareholding
  4:20 pm
RNS
Director/PDMR Shareholding
  4:16 pm
RNS
Director/PDMR Shareholding
10 Feb 2016 1:00 pm
RNS
Director/PDMR Shareholding
03 Feb 2016 12:00 pm
RNS
Final Results
02 Feb 2016 9:46 am
RNS
Director/PDMR Shareholding
01 Feb 2016 5:04 pm
RNS
Director/PDMR Shareholding
  3:41 pm
RNS
Director/PDMR Shareholding
  1:04 pm
RNS
Director/PDMR Shareholding
  1:00 pm
RNS
Director/PDMR Shareholding
  12:57 pm
RNS
Director/PDMR Shareholding
  12:53 pm
RNS
Director/PDMR Shareholding
  12:47 pm
RNS
Total Voting Rights
22 Jan 2016 3:01 pm
RNS
Director/PDMR Shareholding
21 Jan 2016 2:39 pm
RNS
Director/PDMR Shareholding
  2:36 pm
RNS
Director/PDMR Shareholding
18 Jan 2016 10:50 am
RNS
Director/PDMR Shareholding
  10:47 am
RNS
Director/PDMR Shareholding
15 Jan 2016 12:56 pm
RNS
Director/PDMR Shareholding
13 Jan 2016 4:09 pm
RNS
Director/PDMR Shareholding
08 Jan 2016 2:36 pm
RNS
Director/PDMR Shareholding
04 Jan 2016 4:00 pm
RNS
Director/PDMR Shareholding
  3:55 pm
RNS
Director/PDMR Shareholding
  2:28 pm
RNS
Total Voting Rights - Replacement
23 Dec 2015 5:00 pm
RNS
Directorate Change
21 Dec 2015 11:30 am
RNS
Completion of divestment of rights to ofatumumab
18 Dec 2015 11:55 am
RNS
Director/PDMR Shareholding
  7:03 am
RNS
ViiV Healthcare to acquire BMS R&D HIV assets
16 Dec 2015 1:59 pm
RNS
Positive results from sirukumab phIII programme
10 Dec 2015 4:15 pm
RNS
Director/PDMR Shareholding
  11:51 am
RNS
Board Committee changes
02 Dec 2015 4:38 pm
RNS
Nucala European Marketing Authorisation Received
01 Dec 2015 3:21 pm
RNS
Director/PDMR Shareholding
  1:09 pm
RNS
Total Voting Rights
13 Nov 2015 2:14 pm
RNS
Director/PDMR Shareholding
12 Nov 2015 3:41 pm
RNS
Blocklisting Interim Review
11 Nov 2015 3:10 pm
RNS
Director/PDMR Shareholding
05 Nov 2015 7:00 am
RNS
GSK's Nucala? receives approval from US FDA
03 Nov 2015 11:56 am
RNS
ViiV Healthcare announces positive results
  11:56 am
RNS
GSK profiles innovative R&D portfolio to investors
02 Nov 2015 12:45 pm
RNS
Director Declaration
  10:31 am
RNS
Total Voting Rights
29 Oct 2015 3:39 pm
RNS
Director/PDMR Shareholding
28 Oct 2015 12:00 pm
RNS
3rd Quarter Results
  7:00 am
RNS
GSK Exercises Option on OXB LentiVector Patents
27 Oct 2015 10:50 am
RNS
Results of LABA safety study for Advair Diskus
  10:50 am
RNS
90% efficacy in shingles vaccine for over 70's
20 Oct 2015 4:57 pm
RNS
Director/PDMR Shareholding
  4:52 pm
RNS
Director/PDMR Shareholding
  1:20 pm
RNS
Director/PDMR Shareholding
  1:14 pm
RNS
Director/PDMR Shareholding
  1:02 pm
RNS
Positive Data for Incruse Ellipta Comparisons
19 Oct 2015 2:38 pm
RNS
Director/PDMR Shareholding
  2:36 pm
RNS
Director/PDMR Shareholding
  2:34 pm
RNS
Director/PDMR Shareholding
13 Oct 2015 1:54 pm
RNS
Director/PDMR Shareholding
12 Oct 2015 4:52 pm
RNS
Director/PDMR Shareholding
08 Oct 2015 12:29 pm
RNS
Director/PDMR Shareholding
07 Oct 2015 12:26 pm
RNS
Director/PDMR Shareholding
05 Oct 2015 10:00 am
RNS
Director/PDMR Shareholding
02 Oct 2015 2:35 pm
RNS
Director/PDMR Shareholding
  2:32 pm
RNS
Director/PDMR Shareholding
01 Oct 2015 12:07 pm
RNS
Director/PDMR Shareholding
  9:58 am
RNS
Total Voting Rights
30 Sep 2015 1:40 pm
RNS
Director/PDMR Shareholding
28 Sep 2015 4:54 pm
RNS
Director/PDMR Shareholding
24 Sep 2015 2:54 pm
RNS
CHMP opinion for mepolizumab (Nucala) in Europe
  8:03 am
RNS
Intention to file Relvar Ellipta for COPD in Japan
23 Sep 2015 8:30 am
RNS
ViiV Healthcare Phase lllb/IV STRIIVING data
17 Sep 2015 12:13 pm
RNS
Director/PDMR Shareholding
14 Sep 2015 3:52 pm
RNS
Director/PDMR Shareholding
10 Sep 2015 1:06 pm
RNS
Director/PDMR Shareholding
09 Sep 2015 7:00 am
RNS
Results from the SUMMIT COPD CV Survival Study
01 Sep 2015 9:47 am
RNS
Total Voting Rights
  9:43 am
RNS
Director/PDMR Shareholding
  9:41 am
RNS
Director/PDMR Shareholding
28 Aug 2015 3:14 pm
RNS
Director/PDMR Shareholding
27 Aug 2015 12:31 pm
RNS
Director/PDMR Shareholding
21 Aug 2015 7:00 am
RNS
GSK to divest ofatumumab - auto-immune indications
14 Aug 2015 4:49 pm
RNS
Director/PDMR Shareholding
12 Aug 2015 3:32 pm
RNS
Director/PDMR Shareholding
05 Aug 2015 3:41 pm
RNS
Director/PDMR Shareholding
04 Aug 2015 2:25 pm
RNS
Publication of Prospectus
03 Aug 2015 1:39 pm
RNS
Director/PDMR Shareholding
  12:19 pm
RNS
Director/PDMR Shareholding
  11:57 am
RNS
Total Voting Rights
31 Jul 2015 5:22 pm
RNS
Adjusted Free Cash Flow Performance Measure
29 Jul 2015 12:00 pm
RNS
Half Yearly Report
27 Jul 2015 2:45 pm
RNS
Director/PDMR Shareholding
  9:07 am
RNS
Director/PDMR Shareholding
24 Jul 2015 5:18 pm
RNS
Director/PDMR Shareholding
  5:14 pm
RNS
Director/PDMR Shareholding
  5:13 pm
RNS
Director/PDMR Shareholding
  5:06 pm
RNS
Director/PDMR Shareholding
21 Jul 2015 3:14 pm
RNS
Director/PDMR Shareholding
20 Jul 2015 12:45 pm
RNS
Director/PDMR Shareholding
  12:36 pm
RNS
Director/PDMR Shareholding
  12:21 pm
RNS
Director/PDMR Shareholding
10 Jul 2015 4:03 pm
RNS
Director/PDMR Shareholding
  3:58 pm
RNS
Director/PDMR Shareholding
  3:54 pm
RNS
Director/PDMR Shareholding
  1:23 pm
RNS
Director/PDMR Shareholding
07 Jul 2015 12:03 pm
RNS
Director/PDMR Shareholding
01 Jul 2015 3:34 pm
RNS
Director/PDMR Shareholding
  1:56 pm
RNS
Director/PDMR Shareholding
  10:22 am
RNS
Total Voting Rights
24 Jun 2015 10:36 am
RNS
Director/PDMR Shareholding
22 Jun 2015 12:08 pm
RNS
Regulatory update - sale of Nimenrix and Mencevax
12 Jun 2015 7:00 am
RNS
US FDA Advisory Committee on mepolizumab
11 Jun 2015 7:00 am
RNS
Blocklisting Application
10 Jun 2015 3:32 pm
RNS
Director/PDMR Shareholding
09 Jun 2015 10:17 am
RNS
Director/PDMR Shareholding
01 Jun 2015 10:03 am
RNS
Total Voting Rights
28 May 2015 10:52 am
RNS
Director/PDMR Shareholding - Replacement
26 May 2015 10:29 am
RNS
Director/PDMR Shareholding
22 May 2015 3:44 pm
RNS
Director/PDMR Shareholding
  2:46 pm
RNS
Blocklisting Interim Review
15 May 2015 5:16 pm
RNS
Director/PDMR Shareholding
  5:14 pm
RNS
Director/PDMR Shareholding
  5:09 pm
RNS
Director/PDMR Shareholding
13 May 2015 12:16 pm
RNS
Director/PDMR Shareholding
12 May 2015 1:10 pm
RNS
Director/PDMR Shareholding
  1:07 pm
RNS
Director/PDMR Shareholding
11 May 2015 11:44 am
RNS
Director/PDMR Shareholding
  11:38 am
RNS
Director/PDMR Shareholding
08 May 2015 7:00 am
RNS
Result of AGM
07 May 2015 12:30 pm
RNS
Board and Committee changes
06 May 2015 2:20 pm
RNS
Director/PDMR Shareholding
  12:00 pm
RNS
1st Quarter Results
01 May 2015 7:00 am
RNS
Total Voting Rights
  7:00 am
RNS
FDA approves BREO ELLIPTA for adults with asthma
30 Apr 2015 4:53 pm
RNS
Director/PDMR Shareholding
29 Apr 2015 3:25 pm
RNS
Director/PDMR Shareholding
28 Apr 2015 10:52 am
RNS
GSK candidate vaccine for prevention of shingles
  10:42 am
RNS
Director/PDMR Shareholding
23 Apr 2015 4:40 pm
RNS
Director/PDMR Shareholding
20 Apr 2015 2:59 pm
RNS
Director/PDMR Shareholding
  2:06 pm
RNS
Director/PDMR Shareholding
  2:01 pm
RNS
Director/PDMR Shareholding
  1:59 pm
RNS
Director/PDMR Shareholding
14 Apr 2015 3:36 pm
RNS
Director/PDMR Shareholding
  9:35 am
RNS
Director/PDMR Shareholding
13 Apr 2015 6:30 pm
RNS
Director/PDMR Shareholding
  3:32 pm
RNS
Director/PDMR Shareholding
  2:41 pm
RNS
Director/PDMR Shareholding
  2:39 pm
RNS
Director/PDMR Shareholding
10 Apr 2015 2:37 pm
RNS
Director/PDMR Shareholding
08 Apr 2015 1:21 pm
RNS
Director/PDMR Shareholding
01 Apr 2015 4:10 pm
RNS
Director/PDMR Shareholding
  10:33 am
RNS
Total Voting Rights
30 Mar 2015 4:46 pm
RNS
Director/PDMR Shareholding
25 Mar 2015 12:00 pm
RNS
Notice of AGM
20 Mar 2015 7:00 am
RNS
US FDA Advisory Committee on BREO ELLIPTA
19 Mar 2015 2:26 pm
RNS
Director Declaration
16 Mar 2015 3:23 pm
RNS
Director/PDMR Shareholding
13 Mar 2015 7:00 am
RNS
GSK completes partial sale of Aspen
12 Mar 2015 3:14 pm
RNS
GSK intends to sell part holding in Aspen
11 Mar 2015 4:35 pm
RNS
Director/PDMR Shareholding
  4:27 pm
RNS
Director/PDMR Shareholding
09 Mar 2015 5:33 pm
RNS
Director/PDMR Shareholding
06 Mar 2015 5:48 pm
RNS
Director/PDMR Shareholding
02 Mar 2015 2:38 pm
RNS
Director/PDMR Shareholding
  1:30 pm
RNS
Annual Report 2014 on Form 20-F
  11:40 am
RNS
Total Voting Rights
  7:00 am
RNS
GSK completes major three-part transaction
26 Feb 2015 4:03 pm
RNS
Annual Financial Report
  3:16 pm
RNS
Directorate Change
25 Feb 2015 4:21 pm
RNS
Update on three-part transaction with Novartis
20 Feb 2015 1:14 pm
RNS
Director/PDMR Shareholding
  11:57 am
RNS
Director/PDMR Shareholding
19 Feb 2015 6:09 pm
RNS
Director/PDMR Shareholding
  6:09 pm
RNS
Director/PDMR Shareholding
18 Feb 2015 5:05 pm
RNS
Director/PDMR Shareholding
  5:00 pm
RNS
Director/PDMR Shareholding
17 Feb 2015 5:43 pm
RNS
Director/PDMR Shareholding
  5:40 pm
RNS
Director/PDMR Shareholding
  5:06 pm
RNS
Director/PDMR Shareholding
16 Feb 2015 3:05 pm
RNS
Director/PDMR Shareholding
13 Feb 2015 5:36 pm
RNS
Director/PDMR Shareholding
  3:39 pm
RNS
Director/PDMR Shareholding
12 Feb 2015 6:21 pm
RNS
Director/PDMR Shareholding
  6:21 pm
RNS
Director/PDMR Shareholding
  6:19 pm
RNS
Director/PDMR Shareholding
06 Feb 2015 7:00 am
RNS
Positive results from phase III COMBI-d study
05 Feb 2015 7:00 am
RNS
Completion of Accelerated Bookbuild Offering
04 Feb 2015 4:05 pm
RNS
Accelerated Bookbuild Offering - Genmab A/S
  12:00 pm
RNS
Final Results
  11:06 am
RNS
Total Voting Rights - Replacement
02 Feb 2015 12:12 pm
RNS
Director/PDMR Shareholding
  11:49 am
RNS
Director/PDMR Shareholding
28 Jan 2015 5:50 pm
RNS
Director Declaration
  4:55 pm
RNS
Regulatory Update
  3:16 pm
RNS
Director/PDMR Shareholding
27 Jan 2015 2:09 pm
RNS
Board Committee Changes
22 Jan 2015 1:26 pm
RNS
Director/PDMR Shareholding
20 Jan 2015 3:42 pm
RNS
Director/PDMR Shareholding
  3:34 pm
RNS
Director/PDMR Shareholding
19 Jan 2015 5:42 pm
RNS
Director/PDMR Shareholding
  1:29 pm
RNS
Director/PDMR Shareholding
  12:16 pm
RNS
Director/PDMR Shareholding
  12:13 pm
RNS
Director/PDMR Shareholding
15 Jan 2015 3:50 pm
RNS
Director/PDMR Shareholding- Amendment
13 Jan 2015 2:26 pm
RNS
Director/PDMR Shareholding
12 Jan 2015 6:17 pm
RNS
Director/PDMR Shareholding
  5:53 pm
RNS
Director/PDMR Shareholding
09 Jan 2015 4:03 pm
RNS
Director/PDMR Shareholding
  3:17 pm
RNS
Director/PDMR Shareholding
  3:13 pm
RNS
Director/PDMR Shareholding
05 Jan 2015 2:30 pm
RNS
Director/PDMR Shareholding
  2:26 pm
RNS
Director/PDMR Shareholding
  1:44 pm
RNS
Director/PDMR Shareholding
  9:00 am
RNS
Total Voting Rights
30 Dec 2014 2:57 pm
RNS
Director/PDMR Shareholding
18 Dec 2014 12:48 pm
RNS
Result of General Meeting
11 Dec 2014 4:33 pm
RNS
Director/PDMR Shareholding
10 Dec 2014 4:04 pm
RNS
Director/PDMR Shareholding
08 Dec 2014 2:28 pm
RNS
Director/PDMR Shareholding
04 Dec 2014 4:16 pm
RNS
Statement on Established Products Portfolio
01 Dec 2014 12:30 pm
RNS
Total Voting Rights
28 Nov 2014 5:00 pm
RNS
Publication of Final Terms
27 Nov 2014 7:00 am
RNS
Regulatory update on transaction with Novartis
24 Nov 2014 8:48 am
RNS
Director/PDMR Shareholding
  8:06 am
RNS
Publication of Circular and Notice of GM
18 Nov 2014 2:06 pm
RNS
Director/PDMR Shareholding
14 Nov 2014 3:31 pm
RNS
Director/PDMR Shareholding
  12:39 pm
RNS
Director/PDMR Shareholding- Amendment
  12:31 pm
RNS
Director/PDMR Shareholding- Amendment
12 Nov 2014 4:27 pm
RNS
Blocklisting Interim Review
  3:09 pm
RNS
Director/PDMR Shareholding
10 Nov 2014 11:32 am
RNS
Director/PDMR Shareholding
07 Nov 2014 1:51 pm
RNS
Director/PDMR Shareholding
  11:19 am
RNS
Director/PDMR Shareholding
05 Nov 2014 11:22 am
RNS
Regulatory submissions for mepolizumab
03 Nov 2014 11:22 am
RNS
Total Voting Rights
29 Oct 2014 3:53 pm
RNS
Director/PDMR Shareholding
27 Oct 2014 6:34 pm
RNS
Publication of Supplementary Prospectus
  6:30 pm
RNS
Publication of Supplementary Prospectus
  4:15 pm
RNS
Director/PDMR Shareholding
  2:17 pm
RNS
Director/PDMR Shareholding
24 Oct 2014 5:46 pm
RNS
Director/PDMR Shareholding
23 Oct 2014 5:26 pm
RNS
Director/PDMR Shareholding
22 Oct 2014 12:12 pm
RNS
Re Directorate
  12:00 pm
RNS
3rd Quarter Results
20 Oct 2014 4:12 pm
RNS
Director/PDMR Shareholding
  4:08 pm
RNS
Director/PDMR Shareholding
  4:04 pm
RNS
Director/PDMR Shareholding
  3:59 pm
RNS
Director/PDMR Shareholding
14 Oct 2014 5:40 pm
RNS
Director/PDMR Shareholding
  5:34 pm
RNS
Director/PDMR Shareholding
  5:15 pm
RNS
Director/PDMR Shareholding
13 Oct 2014 12:51 pm
RNS
Director/PDMR Shareholding
10 Oct 2014 7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Directorate Change
07 Oct 2014 6:26 pm
RNS
Director/PDMR Shareholding
06 Oct 2014 4:38 pm
RNS
Director/PDMR Shareholding
  3:39 pm
RNS
Director/PDMR Shareholding
03 Oct 2014 4:16 pm
RNS
Directorate Change
  3:13 pm
RNS
Director/PDMR Shareholding
  3:10 pm
RNS
Director/PDMR Shareholding
01 Oct 2014 3:46 pm
RNS
Directorate Change
  3:06 pm
RNS
Director/PDMR Shareholding
  1:25 pm
RNS
Total Voting Rights
29 Sep 2014 1:45 pm
RNS
Director/PDMR Shareholding
25 Sep 2014 1:11 pm
RNS
Director/PDMR Shareholding
  1:08 pm
RNS
Director/PDMR Shareholding
  8:00 am
RNS
Directorate Change
19 Sep 2014 9:06 am
RNS
GSK China Investigation Outcome
16 Sep 2014 8:50 am
RNS
Director/PDMR Shareholding
10 Sep 2014 4:43 pm
RNS
Director/PDMR Shareholding
08 Sep 2014 1:45 pm
RNS
Publication positive study results mepolizumab
03 Sep 2014 1:22 pm
RNS
Triumeq receives EU approval
02 Sep 2014 3:50 pm
RNS
Director/PDMR Shareholding
01 Sep 2014 3:26 pm
RNS
Total Voting Rights
26 Aug 2014 7:19 am
RNS
Triumeq US Approval
22 Aug 2014 11:06 am
RNS
Director/PDMR Shareholding
18 Aug 2014 4:21 pm
RNS
Director/PDMR Shareholding
12 Aug 2014 4:50 pm
RNS
Director/PDMR Shareholding
11 Aug 2014 4:27 pm
RNS
Director/PDMR Shareholding
08 Aug 2014 4:10 pm
RNS
Director/PDMR Shareholding
  4:07 pm
RNS
Director/PDMR Shareholding
05 Aug 2014 10:37 am
RNS
Director/PDMR Shareholding
04 Aug 2014 1:28 pm
RNS
Publication of Prospectus
01 Aug 2014 12:19 pm
RNS
Total Voting Rights
24 Jul 2014 5:47 pm
RNS
Director/PDMR Shareholding
  8:32 am
RNS
Blocklisting Interim Review
23 Jul 2014 12:00 pm
RNS
Half Yearly Report
21 Jul 2014 5:47 pm
RNS
Director/PDMR Shareholding
  5:45 pm
RNS
Director/PDMR Shareholding
  5:44 pm
RNS
Director/PDMR Shareholding
  5:38 pm
RNS
Director/PDMR Shareholding
18 Jul 2014 4:27 pm
RNS
Director/PDMR Shareholding
  4:25 pm
RNS
Director/PDMR Shareholding
  4:24 pm
RNS
Director/PDMR Shareholding
17 Jul 2014 2:00 pm
RNS
MEK/BRAF combination phase III study update
16 Jul 2014 4:59 pm
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Start of phase III study - FF/UMEC/VI combination
14 Jul 2014 4:11 pm
RNS
Director/PDMR Shareholding
  4:11 pm
RNS
Director/PDMR Shareholding
11 Jul 2014 5:07 pm
RNS
Director/PDMR Shareholding
  5:05 pm
RNS
Director/PDMR Shareholding
  5:03 pm
RNS
Director/PDMR Shareholding
10 Jul 2014 4:37 pm
RNS
Director/PDMR Shareholding
  4:23 pm
RNS
Director/PDMR Shareholding
  4:18 pm
RNS
Director/PDMR Shareholding
08 Jul 2014 3:57 pm
RNS
Director/PDMR Shareholding
07 Jul 2014 5:00 pm
RNS
Director/PDMR Shareholding
02 Jul 2014 3:11 pm
RNS
Director/PDMR Shareholding
01 Jul 2014 10:53 am
RNS
Total Voting Rights
30 Jun 2014 5:17 pm
RNS
Director/PDMR Shareholding
  1:00 pm
RNS
Breo Ellipta US regulatory submission
24 Jun 2014 5:30 pm
RNS
Transaction in Own Shares
23 Jun 2014 5:14 pm
RNS
Director/PDMR Shareholding
17 Jun 2014 4:55 pm
RNS
Transaction in Own Shares
16 Jun 2014 5:20 pm
RNS
Transaction in Own Shares
13 Jun 2014 5:46 pm
RNS
Transaction in Own Shares
  2:03 pm
RNS
Director/PDMR Shareholding
12 Jun 2014 4:54 pm
RNS
Transaction in Own Shares
11 Jun 2014 5:36 pm
RNS
Transaction in Own Shares
  3:53 pm
RNS
Director/PDMR Shareholding
  3:50 pm
RNS
Director/PDMR Shareholding
  12:30 pm
RNS
Incruse Ellipta positive data studies
09 Jun 2014 6:01 pm
RNS
Director/PDMR Shareholding
  5:45 pm
RNS
Transaction in Own Shares
06 Jun 2014 4:55 pm
RNS
Transaction in Own Shares
05 Jun 2014 5:34 pm
RNS
Transaction in Own Shares
  3:55 pm
RNS
Director/PDMR Shareholding
04 Jun 2014 5:23 pm
RNS
Transaction in Own Shares
03 Jun 2014 5:39 pm
RNS
Transaction in Own Shares
02 Jun 2014 5:33 pm
RNS
Transaction in Own Shares
  2:02 pm
RNS
Total Voting Rights
30 May 2014 5:34 pm
RNS
Transaction in Own Shares
29 May 2014 6:19 pm
RNS
Transaction in Own Shares
28 May 2014 5:30 pm
RNS
Transaction in Own Shares
  7:00 am
RNS
Serious Fraud Office Investigation
27 May 2014 5:40 pm
RNS
Transaction in Own Shares
  5:32 pm
RNS
Director/PDMR Shareholding
23 May 2014 4:59 pm
RNS
Transaction in Own Shares
21 May 2014 5:40 pm
RNS
Transaction in Own Shares
20 May 2014 5:50 pm
RNS
Transaction in Own Shares
19 May 2014 5:35 pm
RNS
Transaction in Own Shares
16 May 2014 5:36 pm
RNS
Transaction in Own Shares
  4:56 pm
RNS
Director/PDMR Shareholding
  4:55 pm
RNS
Director/PDMR Shareholding
  1:18 pm
RNS
Director Declaration
15 May 2014 5:19 pm
RNS
Transaction in Own Shares
14 May 2014 4:57 pm
RNS
Blocklisting Interim Review
13 May 2014 5:59 pm
RNS
Director/PDMR Shareholding
  5:58 pm
RNS
Director/PDMR Shareholding
  4:02 pm
RNS
Director/PDMR Shareholding
  7:00 am
RNS
darapladib Phase III SOLID Study Results
12 May 2014 4:38 pm
RNS
Director/PDMR Shareholding
  2:52 pm
RNS
Director/PDMR Shareholding
09 May 2014 5:11 pm
RNS
Transaction in Own Shares
08 May 2014 5:43 pm
RNS
Director/PDMR Shareholding
  5:37 pm
RNS
Director/PDMR Shareholding
  5:29 pm
RNS
Transaction in Own Shares
  4:00 pm
RNS
GSK receives EU Marketing Authorisation for Anoro
  12:58 pm
RNS
Board Committee change
07 May 2014 6:06 pm
RNS
Transaction in Own Shares
  5:40 pm
RNS
Director/PDMR Shareholding
  5:19 pm
RNS
Result of AGM
06 May 2014 5:24 pm
RNS
Transaction in Own Shares
  3:28 pm
RNS
Director/PDMR Shareholding
02 May 2014 5:38 pm
RNS
Director/PDMR Shareholding
  5:38 pm
RNS
Director/PDMR Shareholding
  5:34 pm
RNS
Director/PDMR Shareholding
01 May 2014 12:24 pm
RNS
Total Voting Rights
  7:00 am
RNS
GSK receives US approval for Incruse Ellipta
30 Apr 2014 12:00 pm
RNS
1st Quarter Results
28 Apr 2014 4:11 pm
RNS
GSK Receives EU Marketing Authorisation - Incruse
  3:36 pm
RNS
Director/PDMR Shareholding
22 Apr 2014 7:01 am
RNS
GSK announces major transaction with Novartis
17 Apr 2014 4:58 pm
RNS
Director/PDMR Shareholding
  4:58 pm
RNS
Director/PDMR Shareholding
  4:56 pm
RNS
Director/PDMR Shareholding
  4:56 pm
RNS
Director/PDMR Shareholding
  4:52 pm
RNS
Director/PDMR Shareholding
  4:50 pm
RNS
Director/PDMR Shareholding
  4:50 pm
RNS
Director/PDMR Shareholding
  4:24 pm
RNS
GSK receives approval in Canada for Incruse
15 Apr 2014 5:56 pm
RNS
Tanzeum (albiglutide) receives FDA approval
  3:39 pm
RNS
Director/PDMR Shareholding
  3:36 pm
RNS
Director/PDMR Shareholding
14 Apr 2014 4:34 pm
RNS
Director/PDMR Shareholding
11 Apr 2014 3:17 pm
RNS
Director/PDMR Shareholding
  3:15 pm
RNS
Director/PDMR Shareholding
  11:03 am
RNS
Director/PDMR Shareholding
10 Apr 2014 3:14 pm
RNS
Director/PDMR Shareholding
  3:12 pm
RNS
Director/PDMR Shareholding
08 Apr 2014 4:11 pm
RNS
Director/PDMR Shareholding
  4:10 pm
RNS
Director/PDMR Shareholding
02 Apr 2014 10:52 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Update on Phase lll clinical trial of MAGE-A3
01 Apr 2014 12:52 pm
RNS
Total Voting Rights
31 Mar 2014 3:16 pm
RNS
Director/PDMR Shareholding
  7:00 am
RNS
GSK data from PIII STABILITY study of darapladib
26 Mar 2014 1:07 pm
RNS
Eperzan (albiglutide) receives EMA approval
  10:17 am
RNS
Notice of AGM
  10:07 am
RNS
Regulatory update on combined use of MEK/BRAF
24 Mar 2014 9:56 am
RNS
Director/PDMR Shareholding
21 Mar 2014 11:32 am
RNS
GSK - historical restated financial information
20 Mar 2014 7:00 am
RNS
MAGE-A3 MAGRIT Phase III trial results
17 Mar 2014 3:59 pm
RNS
Director/PDMR Shareholding
  3:56 pm
RNS
Director/PDMR Shareholding
13 Mar 2014 4:00 pm
RNS
Additional Listing
12 Mar 2014 5:08 pm
RNS
Mepolizumab Positive Phase III Asthma Study Result
  4:34 pm
RNS
Director/PDMR Shareholding
  4:23 pm
RNS
Director/PDMR Shareholding
10 Mar 2014 7:00 am
RNS
GSK increases stake in its Indian pharma. co.
06 Mar 2014 10:57 am
RNS
Director/PDMR Shareholding
05 Mar 2014 3:14 pm
RNS
Dividend Declaration
03 Mar 2014 4:14 pm
RNS
Director/PDMR Shareholding
  12:39 pm
RNS
Total Voting Rights
  12:28 pm
RNS
GSK files its Annual Report 2013 on form 20F
27 Feb 2014 5:23 pm
RNS
Transaction in Own Shares
  3:11 pm
RNS
Annual Financial Report
26 Feb 2014 5:24 pm
RNS
Transaction in Own Shares
  4:54 pm
RNS
Director/PDMR Shareholding
  4:53 pm
RNS
Director/PDMR Shareholding
  12:22 pm
RNS
Director/PDMR Shareholding
25 Feb 2014 5:16 pm
RNS
Transaction in Own Shares
  2:59 pm
RNS
Director Declaration
  12:26 pm
RNS
Director/PDMR Shareholding
  12:24 pm
RNS
Director/PDMR Shareholding
21 Feb 2014 5:19 pm
RNS
Transaction in Own Shares
  4:25 pm
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Incruse receives positive CHMP opinion
20 Feb 2014 5:29 pm
RNS
Transaction in Own Shares
  12:37 pm
RNS
Anoro receives positive CHMP opinion
17 Feb 2014 5:46 pm
RNS
Director/PDMR Shareholding
  5:36 pm
RNS
Transaction in Own Shares
  4:10 pm
RNS
Director/PDMR Shareholding
  4:10 pm
RNS
Director/PDMR Shareholding
  4:07 pm
RNS
Director/PDMR Shareholding
14 Feb 2014 4:56 pm
RNS
Director/PDMR Shareholding
  4:54 pm
RNS
Director/PDMR Shareholding
13 Feb 2014 4:54 pm
RNS
Director/PDMR Shareholding
  4:52 pm
RNS
Director/PDMR Shareholding
  4:49 pm
RNS
Director/PDMR Shareholding
12 Feb 2014 5:06 pm
RNS
Transaction in Own Shares
  3:34 pm
RNS
Director/PDMR Shareholding
  3:30 pm
RNS
Director/PDMR Shareholding
11 Feb 2014 5:16 pm
RNS
Transaction in Own Shares
  4:14 pm
RNS
Director/PDMR Shareholding
10 Feb 2014 5:54 pm
RNS
Director/PDMR Shareholding
  5:32 pm
RNS
Director/PDMR Shareholding
07 Feb 2014 5:28 pm
RNS
Transaction in Own Shares
06 Feb 2014 5:30 pm
RNS
Transaction in Own Shares
05 Feb 2014 12:00 pm
RNS
Final Results
04 Feb 2014 10:44 am
RNS
Director Declaration
03 Feb 2014 4:01 pm
RNS
Director/PDMR Shareholding
  12:40 pm
RNS
Total Voting Rights
24 Jan 2014 12:31 pm
RNS
MEK/BRAF combination Phase III study results
  10:41 am
RNS
Eperzan (albiglutide) positive CHMP opinion
21 Jan 2014 11:42 am
RNS
Tivicay (dolutegravir) receives European approval
20 Jan 2014 5:24 pm
RNS
Director/PDMR Shareholding
17 Jan 2014 4:55 pm
RNS
Director/PDMR Shareholding
16 Jan 2014 6:24 pm
RNS
Director/PDMR Shareholding
  6:22 pm
RNS
Director/PDMR Shareholding
  6:21 pm
RNS
Director/PDMR Shareholding
  6:20 pm
RNS
Director/PDMR Shareholding
  6:19 pm
RNS
Director/PDMR Shareholding
  12:14 pm
RNS
Director/PDMR Shareholding
15 Jan 2014 4:48 pm
RNS
Replacement Director/PDMR Shareholding
13 Jan 2014 4:50 pm
RNS
Director/PDMR Shareholding
  4:49 pm
RNS
Director/PDMR Shareholding
  2:08 pm
RNS
Director/PDMR Shareholding
  2:08 pm
RNS
Director/PDMR Shareholding
10 Jan 2014 5:34 pm
RNS
Director/PDMR Shareholding
  3:13 pm
RNS
Director/PDMR Shareholding
  3:11 pm
RNS
Director/PDMR Shareholding
09 Jan 2014 5:26 pm
RNS
Director/PDMR Shareholding
  7:00 am
RNS
FDA approves MEK/BRAF combination therapy
06 Jan 2014 4:41 pm
RNS
Director/PDMR Shareholding
03 Jan 2014 9:43 am
RNS
Director/PDMR Shareholding
  9:39 am
RNS
Director/PDMR Shareholding
02 Jan 2014 3:59 pm
RNS
Total Voting Rights
23 Dec 2013 3:08 pm
RNS
Director/PDMR Shareholding
18 Dec 2013 5:02 pm
RNS
FDA approves ANORO ELLIPTA
  7:00 am
RNS
OXB option agreement with GSK
17 Dec 2013 5:50 pm
RNS
Transaction in Own Shares
16 Dec 2013 5:50 pm
RNS
Transaction in Own Shares
  7:00 am
RNS
GSK to increase stake in its Indian pharma. co.
13 Dec 2013 6:11 pm
RNS
Transaction in Own Shares
12 Dec 2013 5:53 pm
RNS
Transaction in Own Shares
11 Dec 2013 5:07 pm
RNS
Transaction in Own Shares
  4:58 pm
RNS
Director/PDMR Shareholding
  4:56 pm
RNS
Director/PDMR Shareholding
  3:31 pm
RNS
Board Committee change
10 Dec 2013 5:16 pm
RNS
Transaction in Own Shares
09 Dec 2013 5:28 pm
RNS
Transaction in Own Shares
  3:54 pm
RNS
Director/PDMR Shareholding
05 Dec 2013 5:53 pm
RNS
Transaction in Own Shares
04 Dec 2013 5:12 pm
RNS
Transaction in Own Shares
03 Dec 2013 5:31 pm
RNS
Transaction in Own Shares
02 Dec 2013 5:03 pm
RNS
Transaction in Own Shares
  12:17 pm
RNS
Total Voting Rights
29 Nov 2013 5:19 pm
RNS
Transaction in Own Shares
  12:40 pm
RNS
Director/PDMR Shareholding
28 Nov 2013 5:48 pm
RNS
Transaction in Own Shares
27 Nov 2013 5:24 pm
RNS
Transaction in Own Shares
25 Nov 2013 5:14 pm
RNS
Director/PDMR Shareholding
22 Nov 2013 1:43 pm
RNS
Tivicay? (dolutegravir) - positive CHMP opinion
20 Nov 2013 7:00 am
RNS
GSK completes partial sale of Aspen
19 Nov 2013 3:21 pm
RNS
GSK intends to divest part holding in Aspen
18 Nov 2013 5:40 pm
RNS
Director/PDMR Shareholding
  1:16 pm
RNS
Relvar Ellipta receives EC marketing authorisation
15 Nov 2013 5:21 pm
RNS
Blocklisting Interim Review
  5:16 pm
RNS
Director/PDMR Shareholding
  5:10 pm
RNS
Transaction in Own Shares
14 Nov 2013 5:17 pm
RNS
Transaction in Own Shares
13 Nov 2013 5:28 pm
RNS
Transaction in Own Shares
12 Nov 2013 3:52 pm
RNS
Director/PDMR Shareholding
  3:51 pm
RNS
Director/PDMR Shareholding
  7:01 am
RNS
darapladib Phase III Study Results
11 Nov 2013 5:06 pm
RNS
Director/PDMR Shareholding
01 Nov 2013 5:29 pm
RNS
Transaction in Own Shares
  12:46 pm
RNS
Total Voting Rights
31 Oct 2013 5:17 pm
RNS
Transaction in Own Shares
30 Oct 2013 5:30 pm
RNS
Transaction in Own Shares
28 Oct 2013 5:38 pm
RNS
Transaction in Own Shares
  3:42 pm
RNS
Director/PDMR Shareholding
25 Oct 2013 5:07 pm
RNS
Transaction in Own Shares
  3:03 pm
RNS
Director/PDMR Shareholding
  1:00 pm
RNS
Dolutegravir Trii - EU Regulatory Submission
23 Oct 2013 12:00 pm
RNS
3rd Quarter Results
22 Oct 2013 5:17 pm
RNS
US FDA submission for Tivicay combination
  4:47 pm
RNS
Transaction in Own Shares
21 Oct 2013 4:54 pm
RNS
Transaction in Own Shares
18 Oct 2013 4:56 pm
RNS
Transaction in Own Shares
17 Oct 2013 4:49 pm
RNS
Transaction in Own Shares
16 Oct 2013 4:48 pm
RNS
Transaction in Own Shares
15 Oct 2013 5:03 pm
RNS
Transaction in Own Shares
  2:01 pm
RNS
Additional Listing
14 Oct 2013 4:54 pm
RNS
Transaction in Own Shares
  3:49 pm
RNS
Director/PDMR Shareholding
  12:28 pm
RNS
Director/PDMR Shareholding
11 Oct 2013 4:50 pm
RNS
Board Committee changes
  4:50 pm
RNS
Transaction in Own Shares
  4:16 pm
RNS
Director/PDMR Shareholding
  3:36 pm
RNS
Director/PDMR Shareholding
10 Oct 2013 4:54 pm
RNS
Transaction in Own Shares
  3:15 pm
RNS
Director/PDMR Shareholding
  3:14 pm
RNS
Director/PDMR Shareholding
  2:45 pm
RNS
Director/PDMR Shareholding
  2:43 pm
RNS
Director/PDMR Shareholding
  2:42 pm
RNS
Director/PDMR Shareholding
  2:41 pm
RNS
Director/PDMR Shareholding
09 Oct 2013 4:50 pm
RNS
Transaction in Own Shares
  12:07 pm
RNS
Director/PDMR Shareholding
  12:04 pm
RNS
Director/PDMR Shareholding
  12:03 pm
RNS
Director/PDMR Shareholding
08 Oct 2013 4:58 pm
RNS
Transaction in Own Shares
  2:31 pm
RNS
Director/PDMR Shareholding
07 Oct 2013 5:15 pm
RNS
Director/PDMR Shareholding
  4:53 pm
RNS
Transaction in Own Shares
04 Oct 2013 5:23 pm
RNS
Transaction in Own Shares
  3:32 pm
RNS
Director/PDMR Shareholding
  3:31 pm
RNS
Director/PDMR Shareholding
  3:29 pm
RNS
Director/PDMR Shareholding
03 Oct 2013 4:54 pm
RNS
Transaction in Own Shares
02 Oct 2013 5:04 pm
RNS
Transaction in Own Shares
01 Oct 2013 4:54 pm
RNS
Transaction in Own Shares
  4:17 pm
RNS
Director/PDMR Shareholding
  12:08 pm
RNS
Total Voting Rights
  10:34 am
RNS
Director/PDMR Shareholding
30 Sep 2013 5:48 pm
RNS
Transaction in Own Shares
  5:30 pm
RNS
Share Buy-Back Programme during close period
  4:28 pm
RNS
Director/PDMR Shareholding
27 Sep 2013 5:10 pm
RNS
Transaction in Own Shares
26 Sep 2013 5:38 pm
RNS
Transaction in Own Shares
25 Sep 2013 4:54 pm
RNS
Transaction in Own Shares
24 Sep 2013 5:04 pm
RNS
Transaction in Own Shares
23 Sep 2013 5:30 pm
RNS
Transaction in Own Shares
20 Sep 2013 5:23 pm
RNS
Transaction in Own Shares
  5:20 pm
RNS
Director/PDMR Shareholding
19 Sep 2013 6:25 pm
RNS
Relvar Ellipta CHMP Positive Opinion
17 Sep 2013 5:19 pm
RNS
Transaction in Own Shares
16 Sep 2013 5:27 pm
RNS
Director/PDMR Shareholding
  5:27 pm
RNS
Transaction in Own Shares
  10:00 am
RNS
dabrafenib/trametinib combo - FDA Priority Review
13 Sep 2013 5:14 pm
RNS
Transaction in Own Shares
12 Sep 2013 5:20 pm
RNS
Transaction in Own Shares
11 Sep 2013 5:23 pm
RNS
Transaction in Own Shares
  3:46 pm
RNS
Director/PDMR Shareholding
  3:44 pm
RNS
Director/PDMR Shareholding
  7:00 am
RNS
FDA AdCom recommends Anoro Ellipta (UMEC/VI)
09 Sep 2013 8:30 am
RNS
GSK to divest Lucozade and Ribena for ?1.35bn
05 Sep 2013 7:00 am
RNS
MAGE A-3 Phase III DERMA Study Results
04 Sep 2013 11:50 am
RNS
Director/PDMR Shareholding
02 Sep 2013 5:22 pm
RNS
Transaction in Own Shares
  12:27 pm
RNS
Total Voting Rights
30 Aug 2013 5:18 pm
RNS
Transaction in Own Shares
29 Aug 2013 5:03 pm
RNS
Transaction in Own Shares
28 Aug 2013 5:08 pm
RNS
Transaction in Own Shares
  2:50 pm
RNS
Director/PDMR Shareholding
  2:48 pm
RNS
Director/PDMR Shareholding
27 Aug 2013 5:01 pm
RNS
Transaction in Own Shares
23 Aug 2013 4:50 pm
RNS
Transaction in Own Shares
22 Aug 2013 4:51 pm
RNS
Transaction in Own Shares
21 Aug 2013 4:40 pm
RNS
Transaction in Own Shares
20 Aug 2013 4:56 pm
RNS
Transaction in Own Shares
19 Aug 2013 3:58 pm
RNS
Director/PDMR Shareholding
16 Aug 2013 4:50 pm
RNS
Transaction in Own Shares
15 Aug 2013 4:58 pm
RNS
Transaction in Own Shares
14 Aug 2013 4:55 pm
RNS
Transaction in Own Shares
13 Aug 2013 7:00 am
RNS
Tivicay? (dolutegravir) receives FDA approval
12 Aug 2013 4:55 pm
RNS
Transaction in Own Shares
  4:23 pm
RNS
Director/PDMR Shareholding
  4:21 pm
RNS
Director/PDMR Shareholding
  12:12 pm
RNS
Director/PDMR Shareholding
09 Aug 2013 5:11 pm
RNS
Transaction in Own Shares
08 Aug 2013 5:11 pm
RNS
Transaction in Own Shares
07 Aug 2013 5:01 pm
RNS
Transaction in Own Shares
06 Aug 2013 5:06 pm
RNS
Transaction in Own Shares
  4:25 pm
RNS
Director/PDMR Shareholding
05 Aug 2013 4:30 pm
RNS
Director/PDMR Shareholding
  12:35 pm
RNS
Publication of Prospectus
02 Aug 2013 5:13 pm
RNS
Transaction in Own Shares
  3:05 pm
RNS
Regulatory Update - Albiglutide
01 Aug 2013 5:00 pm
RNS
Transaction in Own Shares
  2:13 pm
RNS
Total Voting Rights
31 Jul 2013 5:05 pm
RNS
Transaction in Own Shares
  12:41 pm
RNS
Director/PDMR Shareholding
24 Jul 2013 12:00 pm
RNS
Half Yearly Report
23 Jul 2013 4:52 pm
RNS
Transaction in Own Shares
22 Jul 2013 5:01 pm
RNS
Transaction in Own Shares
  4:11 pm
RNS
Director/PDMR Shareholding
  3:53 pm
RNS
Director/PDMR Shareholding
  11:36 am
RNS
GSK Consumer Nigeria plc Sch of Arrangement update
19 Jul 2013 10:59 am
RNS
Director/PDMR Shareholding
  10:57 am
RNS
Director/PDMR Shareholding
  10:52 am
RNS
Director/PDMR Shareholding
18 Jul 2013 12:24 pm
RNS
Director/PDMR Shareholding
17 Jul 2013 5:18 pm
RNS
Director/PDMR Shareholding
  5:16 pm
RNS
Director/PDMR Shareholding
  5:16 pm
RNS
Director/PDMR Shareholding
16 Jul 2013 2:40 pm
RNS
Director/PDMR Shareholding
  2:40 pm
RNS
Director/PDMR Shareholding
12 Jul 2013 4:46 pm
RNS
Director/PDMR Shareholding
  2:14 pm
RNS
Director/PDMR Shareholding
  2:13 pm
RNS
Director/PDMR Shareholding
11 Jul 2013 2:26 pm
RNS
Director/PDMR Shareholding
  2:21 pm
RNS
Director/PDMR Shareholding
  9:45 am
RNS
Holding(s) in Company
10 Jul 2013 3:13 pm
RNS
Director/PDMR Shareholding
  3:12 pm
RNS
Director/PDMR Shareholding
09 Jul 2013 12:36 pm
RNS
Director/PDMR Shareholding
  12:31 pm
RNS
Director/PDMR Shareholding
  7:00 am
RNS
US submission for BRAF/MEK combination therapy
04 Jul 2013 4:53 pm
RNS
Transaction in Own Shares
03 Jul 2013 6:04 pm
RNS
Director/PDMR Shareholding
  4:47 pm
RNS
Transaction in Own Shares
02 Jul 2013 4:44 pm
RNS
Transaction in Own Shares
01 Jul 2013 4:55 pm
RNS
Director/PDMR Shareholding
  4:55 pm
RNS
Director/PDMR Shareholding
  4:55 pm
RNS
Transaction in Own Shares
  4:53 pm
RNS
Director/PDMR Shareholding
  3:46 pm
RNS
Director/PDMR Shareholding
  11:17 am
RNS
Total Voting Rights
28 Jun 2013 6:18 pm
RNS
Share Buy-Back Programme during close period
  5:43 pm
RNS
Transaction in Own Shares
27 Jun 2013 5:13 pm
RNS
Transaction in Own Shares
26 Jun 2013 5:27 pm
RNS
Transaction in Own Shares
25 Jun 2013 5:12 pm
RNS
Transaction in Own Shares
24 Jun 2013 5:39 pm
RNS
Transaction in Own Shares
  4:46 pm
RNS
Director/PDMR Shareholding
  10:00 am
RNS
albiglutide-data from five phase III studies
21 Jun 2013 4:55 pm
RNS
Transaction in Own Shares
20 Jun 2013 5:11 pm
RNS
Transaction in Own Shares
  11:45 am
RNS
Director/PDMR Shareholding
19 Jun 2013 5:22 pm
RNS
Transaction in Own Shares
18 Jun 2013 5:00 pm
RNS
Transaction in Own Shares
  12:00 pm
RNS
GSK receives offer for Thrombosis Brands
17 Jun 2013 5:30 pm
RNS
Transaction in Own Shares
14 Jun 2013 5:16 pm
RNS
Transaction in Own Shares
13 Jun 2013 5:32 pm
RNS
Transaction in Own Shares
12 Jun 2013 5:11 pm
RNS
Transaction in Own Shares
  4:18 pm
RNS
Director/PDMR Shareholding
  4:16 pm
RNS
Director/PDMR Shareholding
11 Jun 2013 5:24 pm
RNS
Transaction in Own Shares
10 Jun 2013 5:11 pm
RNS
Director/PDMR Shareholding
07 Jun 2013 5:20 pm
RNS
Transaction in Own Shares
06 Jun 2013 5:39 pm
RNS
Transaction in Own Shares
05 Jun 2013 5:16 pm
RNS
Transaction in Own Shares
  5:06 pm
RNS
Director/PDMR Shareholding
  2:03 pm
RNS
Director/PDMR Shareholding
04 Jun 2013 5:32 pm
RNS
Transaction in Own Shares
03 Jun 2013 5:46 pm
RNS
Transaction in Own Shares
  2:14 pm
RNS
Total Voting Rights
31 May 2013 5:46 pm
RNS
Transaction in Own Shares
30 May 2013 5:25 pm
RNS
Transaction in Own Shares
29 May 2013 5:07 pm
RNS
Transaction in Own Shares
28 May 2013 5:21 pm
RNS
Transaction in Own Shares
  4:05 pm
RNS
Director/PDMR Shareholding
24 May 2013 5:11 pm
RNS
Transaction in Own Shares
23 May 2013 5:18 pm
RNS
Transaction in Own Shares
21 May 2013 5:16 pm
RNS
Transaction in Own Shares
20 May 2013 5:14 pm
RNS
Transaction in Own Shares
17 May 2013 5:58 pm
RNS
Transaction in Own Shares
  4:12 pm
RNS
Director/PDMR Shareholding
  2:34 pm
RNS
Director/PDMR Shareholding
  9:51 am
RNS
Blocklisting Interim Review
16 May 2013 4:23 pm
RNS
Director/PDMR Shareholding
15 May 2013 6:07 pm
RNS
Director/PDMR Shareholding
  5:38 pm
RNS
Transaction in Own Shares
14 May 2013 6:27 pm
RNS
Director/PDMR Shareholding
  5:29 pm
RNS
Transaction in Own Shares
13 May 2013 5:53 pm
RNS
Transaction in Own Shares
  5:01 pm
RNS
Director/PDMR Shareholding
  5:01 pm
RNS
Director/PDMR Shareholding
  4:55 pm
RNS
Doc re. (AGM Statement)
  4:54 pm
RNS
Director/PDMR Shareholding
10 May 2013 5:31 pm
RNS
Director/PDMR Shareholding
  5:03 pm
RNS
Breo Ellipta FDA Approval
08 May 2013 4:12 pm
RNS
Director/PDMR Shareholding
  12:23 pm
RNS
Additional Listing
07 May 2013 5:21 pm
RNS
Director/PDMR Shareholding
02 May 2013 5:56 pm
RNS
Corporate Responsibility Committee member change
01 May 2013 5:32 pm
RNS
Result of AGM
  7:00 am
RNS
Total Voting Rights
30 Apr 2013 1:00 pm
RNS
UMEC US Regulatory Submission
29 Apr 2013 6:10 pm
RNS
Director/PDMR Shareholding
  4:05 pm
RNS
Director/PDMR Shareholding
26 Apr 2013 10:00 am
RNS
UMEC EU Regulatory Submission
25 Apr 2013 5:16 pm
RNS
Director/PDMR Shareholding
24 Apr 2013 12:00 pm
RNS
1st Quarter Results
19 Apr 2013 4:23 pm
RNS
Director/PDMR Shareholding
  4:20 pm
RNS
Director/PDMR Shareholding
  4:19 pm
RNS
Director/PDMR Shareholding
  4:19 pm
RNS
Director/PDMR Shareholding
18 Apr 2013 7:00 am
RNS
Breo Ellipta FDA AdCom Vote
17 Apr 2013 5:22 pm
RNS
Director/PDMR Shareholding
  5:21 pm
RNS
Director/PDMR Shareholding
  5:20 pm
RNS
Director/PDMR Shareholding
  5:19 pm
RNS
Director/PDMR Shareholding
  5:16 pm
RNS
Director/PDMR Shareholding
16 Apr 2013 9:55 am
RNS
Director/PDMR Shareholding
15 Apr 2013 5:51 pm
RNS
Director/PDMR Shareholding
  5:49 pm
RNS
Director/PDMR Shareholding
  5:47 pm
RNS
Director/PDMR Shareholding
12 Apr 2013 5:12 pm
RNS
Director/PDMR Shareholding
  5:11 pm
RNS
Director/PDMR Shareholding
11 Apr 2013 5:24 pm
RNS
Director/PDMR Shareholding
  5:22 pm
RNS
Director/PDMR Shareholding
04 Apr 2013 5:10 pm
RNS
Director/PDMR Shareholding
  11:34 am
RNS
Additional Listing
02 Apr 2013 12:14 pm
RNS
Directorate Change
  12:07 pm
RNS
Total Voting Rights
28 Mar 2013 4:55 pm
RNS
Director/PDMR Shareholding
27 Mar 2013 5:04 pm
RNS
Transaction in Own Shares
26 Mar 2013 5:03 pm
RNS
Transaction in Own Shares
25 Mar 2013 5:21 pm
RNS
Transaction in Own Shares
  4:25 pm
RNS
Director/PDMR Shareholding
  3:01 pm
RNS
Director/PDMR Shareholding
22 Mar 2013 5:16 pm
RNS
Transaction in Own Shares
21 Mar 2013 5:17 pm
RNS
Transaction in Own Shares
19 Mar 2013 5:50 pm
RNS
Director/PDMR Shareholding
18 Mar 2013 5:30 pm
RNS
Director/PDMR Shareholding
  5:10 pm
RNS
Transaction in Own Shares
  5:04 pm
RNS
Director/PDMR Shareholding
  5:02 pm
RNS
Director/PDMR Shareholding
  5:00 pm
RNS
Director/PDMR Shareholding
15 Mar 2013 5:23 pm
RNS
Transaction in Own Shares
14 Mar 2013 5:36 pm
RNS
Transaction in Own Shares
13 Mar 2013 5:28 pm
RNS
Transaction in Own Shares
12 Mar 2013 5:36 pm
RNS
Transaction in Own Shares
  3:49 pm
RNS
Director/PDMR Shareholding
  3:34 pm
RNS
Director/PDMR Shareholding
11 Mar 2013 5:19 pm
RNS
Transaction in Own Shares
  10:52 am
RNS
GSK files its Annual Report 2012 on Form 20-F
08 Mar 2013 5:23 pm
RNS
Transaction in Own Shares
07 Mar 2013 5:43 pm
RNS
Transaction in Own Shares
  10:32 am
RNS
GSK submits albiglutide MAA to the EMA
  7:00 am
RNS
Dolutegravir SAILING study in HIV announced
06 Mar 2013 5:38 pm
RNS
Director/PDMR Shareholding
  2:33 pm
RNS
Publication of Annual Report 2012
05 Mar 2013 5:45 pm
RNS
Director/PDMR Shareholding
  5:43 pm
RNS
Director/PDMR Shareholding
  5:36 pm
RNS
Director/PDMR Shareholding
  5:35 pm
RNS
Director/PDMR Shareholding
  5:33 pm
RNS
Director/PDMR Shareholding
  2:48 pm
RNS
Director/PDMR Shareholding
  2:45 pm
RNS
Director/PDMR Shareholding
04 Mar 2013 6:27 pm
RNS
Director/PDMR Shareholding
  6:26 pm
RNS
Director/PDMR Shareholding
  6:25 pm
RNS
Director/PDMR Shareholding
  6:23 pm
RNS
Director/PDMR Shareholding
  4:36 pm
RNS
Director/PDMR Shareholding
01 Mar 2013 2:54 pm
RNS
Total Voting Rights
25 Feb 2013 9:56 am
RNS
Director/PDMR Shareholding
19 Feb 2013 6:04 pm
RNS
Director/PDMR Shareholding
18 Feb 2013 4:58 pm
RNS
Director/PDMR Shareholding
15 Feb 2013 3:09 pm
RNS
Dolutegravir granted FDA priority review
12 Feb 2013 3:15 pm
RNS
Director/PDMR Shareholding
  3:11 pm
RNS
Director/PDMR Shareholding
08 Feb 2013 4:38 pm
RNS
Replacement Director/PDMR Shareholding
07 Feb 2013 3:24 pm
RNS
EU submission for BRAF/MEK combination therapy
06 Feb 2013 12:16 pm
RNS
GSK applies IAS19R with effect from 1 January 2013
  12:01 pm
RNS
Final Results
05 Feb 2013 2:09 pm
RNS
Director/PDMR Shareholding
  7:30 am
RNS
GSK increases stake in its Indian consumer co.
01 Feb 2013 4:56 pm
RNS
Total Voting Rights
31 Jan 2013 4:21 pm
RNS
Director/PDMR Shareholding
24 Jan 2013 3:37 pm
RNS
Directorate Change
21 Jan 2013 4:53 pm
RNS
Director/PDMR Shareholding
14 Jan 2013 10:00 am
RNS
GSK submits albiglutide BLA to the US FDA
11 Jan 2013 5:11 pm
RNS
Director/PDMR Shareholding
  5:11 pm
RNS
Director/PDMR Shareholding
10 Jan 2013 5:00 pm
RNS
Director/PDMR Shareholding
  5:00 pm
RNS
Director/PDMR Shareholding
  4:54 pm
RNS
Director/PDMR Shareholding
  4:51 pm
RNS
Director/PDMR Shareholding
  4:47 pm
RNS
Director/PDMR Shareholding
09 Jan 2013 5:31 pm
RNS
Director/PDMR Shareholding
  5:26 pm
RNS
Director/PDMR Shareholding
  5:20 pm
RNS
Director/PDMR Shareholding
  12:00 pm
RNS
Update on UMEC/VI (ANORO)
08 Jan 2013 12:24 pm
RNS
Director/PDMR Shareholding
07 Jan 2013 5:42 pm
RNS
Director/PDMR Shareholding
  5:14 pm
RNS
Director/PDMR Shareholding
  5:13 pm
RNS
Director/PDMR Shareholding
  5:11 pm
RNS
Director/PDMR Shareholding
04 Jan 2013 5:12 pm
RNS
Director/PDMR Shareholding
  5:08 pm
RNS
Director/PDMR Shareholding
  5:05 pm
RNS
Director/PDMR Shareholding
  5:03 pm
RNS
Director/PDMR Shareholding
02 Jan 2013 4:43 pm
RNS
Director/PDMR Shareholding
  4:37 pm
RNS
Director/PDMR Shareholding
  11:51 am
RNS
Total Voting Rights
21 Dec 2012 12:17 pm
RNS
Director/PDMR Shareholding
19 Dec 2012 4:59 pm
RNS
Director/PDMR Shareholding
18 Dec 2012 12:01 pm
RNS
Update on UMEC/VI (LAMA/LABA
17 Dec 2012 5:07 pm
RNS
ViiV files Dolutegravir with EU, US and Canada
  9:56 am
RNS
Issue of Debt
14 Dec 2012 5:36 pm
RNS
Transaction in Own Shares
13 Dec 2012 6:15 pm
RNS
Transaction in Own Shares
12 Dec 2012 5:38 pm
RNS
Transaction in Own Shares
  5:30 pm
RNS
Director/PDMR Shareholding
  5:21 pm
RNS
Director/PDMR Shareholding
11 Dec 2012 5:45 pm
RNS
Transaction in Own Shares
10 Dec 2012 5:36 pm
RNS
Transaction in Own Shares
  5:23 pm
RNS
Director/PDMR Shareholding
07 Dec 2012 5:56 pm
RNS
Director/PDMR Shareholding
  5:39 pm
RNS
Transaction in Own Shares
  7:00 am
RNS
Publication of Prospectus
06 Dec 2012 5:38 pm
RNS
Transaction in Own Shares
05 Dec 2012 6:25 pm
RNS
Transaction in Own Shares
04 Dec 2012 5:55 pm
RNS
Transaction in Own Shares
03 Dec 2012 6:24 pm
RNS
Transaction in Own Shares
  2:15 pm
RNS
Total Voting Rights
30 Nov 2012 6:09 pm
RNS
Transaction in Own Shares
  12:30 pm
RNS
Director/PDMR Shareholding
  12:24 pm
RNS
Director/PDMR Shareholding
29 Nov 2012 5:46 pm
RNS
Transaction in Own Shares
28 Nov 2012 5:11 pm
RNS
Transaction in Own Shares
27 Nov 2012 5:46 pm
RNS
Transaction in Own Shares
26 Nov 2012 4:59 pm
RNS
Director/PDMR Shareholding
  7:00 am
RNS
GSK to increase stake in its Nigerian Consumer co.
  7:00 am
RNS
GSK to increase stake in its Indian consumer co.
23 Nov 2012 5:58 pm
RNS
Transaction in Own Shares
22 Nov 2012 5:36 pm
RNS
Transaction in Own Shares
21 Nov 2012 6:01 pm
RNS
Transaction in Own Shares
20 Nov 2012 5:44 pm
RNS
Transaction in Own Shares
19 Nov 2012 5:32 pm
RNS
Transaction in Own Shares
16 Nov 2012 5:34 pm
RNS
Transaction in Own Shares
  5:07 pm
RNS
Director/PDMR Shareholding
15 Nov 2012 6:16 pm
RNS
Transaction in Own Shares
14 Nov 2012 5:25 pm
RNS
Transaction in Own Shares
13 Nov 2012 5:47 pm
RNS
Transaction in Own Shares
12 Nov 2012 5:36 pm
RNS
Transaction in Own Shares
  4:22 pm
RNS
Director/PDMR Shareholding
  4:19 pm
RNS
Director/PDMR Shareholding
  4:17 pm
RNS
Director/PDMR Shareholding
09 Nov 2012 5:41 pm
RNS
Transaction in Own Shares
08 Nov 2012 5:48 pm
RNS
Transaction in Own Shares
  5:28 pm
RNS
Blocklisting Interim Review
07 Nov 2012 5:36 pm
RNS
Transaction in Own Shares
06 Nov 2012 5:50 pm
RNS
Transaction in Own Shares
  4:06 pm
RNS
Director/PDMR Shareholding
05 Nov 2012 5:30 pm
RNS
Transaction in Own Shares
02 Nov 2012 5:37 pm
RNS
Transaction in Own Shares
01 Nov 2012 6:04 pm
RNS
HGS 3.00% convertible senior notes 2018
  5:36 pm
RNS
Transaction in Own Shares
  5:22 pm
RNS
Total Voting Rights
31 Oct 2012 5:19 pm
RNS
Transaction in Own Shares
  12:00 pm
RNS
3rd Quarter Results
30 Oct 2012 4:49 pm
RNS
Director/PDMR Shareholding
  4:45 pm
RNS
Transaction in Own Shares
29 Oct 2012 4:55 pm
RNS
Transaction in Own Shares
  3:07 pm
RNS
Director/PDMR Shareholding
  7:00 am
RNS
ViiV Healthcare and Shionogi enter new agreement
26 Oct 2012 4:53 pm
RNS
Transaction in Own Shares
25 Oct 2012 5:03 pm
RNS
Transaction in Own Shares
24 Oct 2012 5:03 pm
RNS
Transaction in Own Shares
23 Oct 2012 4:53 pm
RNS
Transaction in Own Shares
22 Oct 2012 4:55 pm
RNS
Transaction in Own Shares
19 Oct 2012 4:54 pm
RNS
Transaction in Own Shares
18 Oct 2012 4:55 pm
RNS
Transaction in Own Shares
17 Oct 2012 4:55 pm
RNS
Transaction in Own Shares
16 Oct 2012 4:58 pm
RNS
Transaction in Own Shares
15 Oct 2012 5:39 pm
RNS
Director/PDMR Shareholding
  5:15 pm
RNS
Transaction in Own Shares
  3:36 pm
RNS
Director/PDMR Shareholding
  12:34 pm
RNS
Additional Listing
12 Oct 2012 4:52 pm
RNS
Transaction in Own Shares
11 Oct 2012 4:54 pm
RNS
Transaction in Own Shares
  4:50 pm
RNS
Director/PDMR Shareholding
  4:49 pm
RNS
Director/PDMR Shareholding
  4:28 pm
RNS
Director/PDMR Shareholding
  4:26 pm
RNS
Director/PDMR Shareholding
  12:53 pm
RNS
Director/PDMR Shareholding
  12:50 pm
RNS
Director/PDMR Shareholding
10 Oct 2012 6:04 pm
RNS
Director/PDMR Shareholding
  5:54 pm
RNS
Director/PDMR Shareholding
  5:48 pm
RNS
Director/PDMR Shareholding
  5:46 pm
RNS
Director/PDMR Shareholding
  5:35 pm
RNS
Director/PDMR Shareholding
  4:55 pm
RNS
Transaction in Own Shares
09 Oct 2012 4:55 pm
RNS
Transaction in Own Shares
  11:43 am
RNS
Director/PDMR Shareholding
08 Oct 2012 4:55 pm
RNS
Transaction in Own Shares
05 Oct 2012 5:50 pm
RNS
Director/PDMR Shareholding
  4:55 pm
RNS
Transaction in Own Shares
  4:17 pm
RNS
Director/PDMR Shareholding
  4:12 pm
RNS
Director/PDMR Shareholding
04 Oct 2012 5:00 pm
RNS
Transaction in Own Shares
  7:00 am
RNS
Completion of dolutegravir registration package
03 Oct 2012 5:00 pm
RNS
Transaction in Own Shares
02 Oct 2012 5:00 pm
RNS
Transaction in Own Shares
  2:02 pm
RNS
Director/PDMR Shareholding
01 Oct 2012 5:38 pm
RNS
Transaction in Own Shares
  5:35 pm
RNS
Director/PDMR Shareholding
  3:04 pm
RNS
Director/PDMR Shareholding
  2:56 pm
RNS
Total Voting Rights
28 Sep 2012 6:00 pm
RNS
Share Buy-Back Programme during close period
  5:05 pm
RNS
Transaction in Own Shares
27 Sep 2012 5:09 pm
RNS
Transaction in Own Shares
26 Sep 2012 5:16 pm
RNS
Transaction in Own Shares
  1:55 pm
RNS
Directorate Change
25 Sep 2012 5:13 pm
RNS
Transaction in Own Shares
24 Sep 2012 5:21 pm
RNS
Transaction in Own Shares
  3:39 pm
RNS
Director/PDMR Shareholding
21 Sep 2012 5:29 pm
RNS
Transaction in Own Shares
20 Sep 2012 5:22 pm
RNS
Transaction in Own Shares
19 Sep 2012 5:11 pm
RNS
Transaction in Own Shares
18 Sep 2012 5:16 pm
RNS
Transaction in Own Shares
17 Sep 2012 5:37 pm
RNS
Director/PDMR Shareholding
  5:24 pm
RNS
Transaction in Own Shares
14 Sep 2012 5:15 pm
RNS
Transaction in Own Shares
13 Sep 2012 5:25 pm
RNS
Transaction in Own Shares
  1:00 pm
RNS
GSK acquires shares in Response Genetics Inc
  11:59 am
RNS
Director/PDMR Shareholding
  11:55 am
RNS
Director/PDMR Shareholding
12 Sep 2012 5:50 pm
RNS
Transaction in Own Shares
11 Sep 2012 5:15 pm
RNS
Transaction in Own Shares
10 Sep 2012 5:44 pm
RNS
Transaction in Own Shares
07 Sep 2012 5:21 pm
RNS
Transaction in Own Shares
  2:48 pm
RNS
HGS 3.00% convertible senior notes 2018
06 Sep 2012 5:49 pm
RNS
Transaction in Own Shares
05 Sep 2012 5:09 pm
RNS
Transaction in Own Shares
  2:26 pm
RNS
Publication of Prospectus
  2:25 pm
RNS
Publication of Prospectus
  10:00 am
RNS
Director/PDMR Shareholding
04 Sep 2012 5:19 pm
RNS
Transaction in Own Shares
  9:10 am
RNS
Transaction in Own Shares
03 Sep 2012 12:32 pm
RNS
Total Voting Rights
31 Aug 2012 5:08 pm
RNS
Transaction in Own Shares
30 Aug 2012 5:22 pm
RNS
Transaction in Own Shares
29 Aug 2012 5:16 pm
RNS
Transaction in Own Shares
28 Aug 2012 5:01 pm
RNS
Transaction in Own Shares
24 Aug 2012 5:03 pm
RNS
Transaction in Own Shares
  12:00 pm
RNS
Completion of Ph III programme for LABA/LAMA
23 Aug 2012 5:40 pm
RNS
Transaction in Own Shares
  3:15 pm
RNS
Director/PDMR Shareholding
  3:12 pm
RNS
Director/PDMR Shareholding
22 Aug 2012 5:07 pm
RNS
Transaction in Own Shares
21 Aug 2012 5:34 pm
RNS
Transaction in Own Shares
20 Aug 2012 6:20 pm
RNS
GSK Divests of "Classic Brands" in Australia
  5:07 pm
RNS
Transaction in Own Shares
  12:08 pm
RNS
Director/PDMR Shareholding
17 Aug 2012 4:59 pm
RNS
Transaction in Own Shares
16 Aug 2012 5:10 pm
RNS
Transaction in Own Shares
15 Aug 2012 4:54 pm
RNS
Transaction in Own Shares
14 Aug 2012 5:16 pm
RNS
Transaction in Own Shares
13 Aug 2012 4:55 pm
RNS
Transaction in Own Shares
10 Aug 2012 5:13 pm
RNS
Transaction in Own Shares
  4:04 pm
RNS
Director/PDMR Shareholding
  3:56 pm
RNS
Director/PDMR Shareholding
  3:49 pm
RNS
Director/PDMR Shareholding
09 Aug 2012 5:03 pm
RNS
Transaction in Own Shares
08 Aug 2012 5:04 pm
RNS
Transaction in Own Shares
07 Aug 2012 4:45 pm
RNS
Transaction in Own Shares
  3:05 pm
RNS
Director/PDMR Shareholding
06 Aug 2012 5:00 pm
RNS
Transaction in Own Shares
  3:51 pm
RNS
Director/PDMR Shareholding
03 Aug 2012 4:53 pm
RNS
Transaction in Own Shares
02 Aug 2012 5:12 pm
RNS
Transaction in Own Shares
01 Aug 2012 5:07 pm
RNS
Transaction in Own Shares
  11:47 am
RNS
Total Voting Rights
31 Jul 2012 5:00 pm
RNS
Transaction in Own Shares
30 Jul 2012 5:09 pm
RNS
Transaction in Own Shares
  1:30 pm
RNS
GSK announces initial tender offer results for HGS
27 Jul 2012 5:19 pm
RNS
Transaction in Own Shares
  12:42 pm
RNS
Director/PDMR Shareholding
26 Jul 2012 5:00 pm
RNS
Transaction in Own Shares
25 Jul 2012 12:00 pm
RNS
Half Yearly Report
23 Jul 2012 5:13 pm
RNS
Director/PDMR Shareholding
19 Jul 2012 4:10 pm
RNS
Director/PDMR Shareholding
17 Jul 2012 6:26 pm
RNS
Director/PDMR Shareholding
  3:38 pm
RNS
Director/PDMR Shareholding
16 Jul 2012 2:15 pm
RNS
GSK to acquire HGS for $14.25 per share in cash
12 Jul 2012 5:53 pm
RNS
Director/PDMR Shareholding
  5:51 pm
RNS
Director/PDMR Shareholding
  5:47 pm
RNS
Director/PDMR Shareholding
11 Jul 2012 4:00 pm
RNS
GSK announces positive data from Harmony 8 study
  3:58 pm
RNS
Director/PDMR Shareholding
  3:56 pm
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Positive data for dolutegravir vs Atripla
10 Jul 2012 5:49 pm
RNS
Director/PDMR Shareholding
  5:47 pm
RNS
Director/PDMR Shareholding
  5:46 pm
RNS
Director/PDMR Shareholding
  5:44 pm
RNS
Director/PDMR Shareholding
  2:42 pm
RNS
Director/PDMR Shareholding
09 Jul 2012 3:37 pm
RNS
Director/PDMR Shareholding
06 Jul 2012 6:03 pm
RNS
Director/PDMR Shareholding
  5:22 pm
RNS
Director/PDMR Shareholding
  5:02 pm
RNS
Director/PDMR Shareholding
  4:01 pm
RNS
Director/PDMR Shareholding
  3:57 pm
RNS
Director/PDMR Shareholding
02 Jul 2012 3:42 pm
RNS
GSK concludes settlement with US Government
  3:11 pm
RNS
Director/PDMR Shareholding
  12:18 pm
RNS
Total Voting Rights
  7:00 am
RNS
GSK announces Ph III data for LABA/LAMA in COPD
29 Jun 2012 12:00 pm
RNS
GSK sets expiration of tender offer to acquire HGS
28 Jun 2012 5:26 pm
RNS
Transaction in Own Shares
27 Jun 2012 5:43 pm
RNS
Transaction in Own Shares
26 Jun 2012 5:50 pm
RNS
Transaction in Own Shares
  3:03 pm
RNS
GSK publish 2011 core operating profit by segment
25 Jun 2012 5:23 pm
RNS
Transaction in Own Shares
  4:42 pm
RNS
Director/PDMR Shareholding
22 Jun 2012 5:23 pm
RNS
Transaction in Own Shares
21 Jun 2012 5:13 pm
RNS
Transaction in Own Shares
20 Jun 2012 5:37 pm
RNS
Transaction in Own Shares
19 Jun 2012 5:35 pm
RNS
Transaction in Own Shares
18 Jun 2012 5:11 pm
RNS
Transaction in Own Shares
15 Jun 2012 5:25 pm
RNS
Transaction in Own Shares
  3:03 pm
RNS
GSK continues with tender offer to acquire HGS
14 Jun 2012 5:14 pm
RNS
Transaction in Own Shares
  4:56 pm
RNS
Director/PDMR Shareholding
  4:48 pm
RNS
Director/PDMR Shareholding
13 Jun 2012 5:52 pm
RNS
Transaction in Own Shares
12 Jun 2012 5:21 pm
RNS
Transaction in Own Shares
  7:00 am
RNS
GSK signs worldwide acquisition for Toctino
11 Jun 2012 5:46 pm
RNS
Transaction in Own Shares
  4:33 pm
RNS
Director/PDMR Shareholding
08 Jun 2012 5:46 pm
RNS
Transaction in Own Shares
  1:30 pm
RNS
GSK extends tender offer for shares of HGS
07 Jun 2012 5:06 pm
RNS
Transaction in Own Shares
06 Jun 2012 6:01 pm
RNS
Transaction in Own Shares
  4:25 pm
RNS
Director/PDMR Shareholding
  2:01 pm
RNS
Director/PDMR Shareholding
01 Jun 2012 5:27 pm
RNS
Transaction in Own Shares
  1:30 pm
RNS
GSK update on tender offer to acquire HGS
  12:01 pm
RNS
Total Voting Rights
31 May 2012 5:42 pm
RNS
Transaction in Own Shares
30 May 2012 5:28 pm
RNS
Transaction in Own Shares
29 May 2012 5:56 pm
RNS
Director/PDMR Shareholding
  5:29 pm
RNS
Transaction in Own Shares
28 May 2012 5:13 pm
RNS
Transaction in Own Shares
  4:38 pm
RNS
Director/PDMR Shareholding
25 May 2012 5:09 pm
RNS
Transaction in Own Shares
24 May 2012 5:53 pm
RNS
Transaction in Own Shares
23 May 2012 5:50 pm
RNS
Transaction in Own Shares
  1:30 pm
RNS
GSK amends HGS tender offer conditions
22 May 2012 5:47 pm
RNS
Transaction in Own Shares
21 May 2012 6:20 pm
RNS
Director/PDMR Shareholding (Replacement)
  5:38 pm
RNS
Transaction in Own Shares
18 May 2012 5:22 pm
RNS
Transaction in Own Shares
17 May 2012 6:15 pm
RNS
Transaction in Own Shares
  6:10 pm
RNS
GSK statement on tender offer to acquire HGS
16 May 2012 5:20 pm
RNS
Director Declaration
  5:15 pm
RNS
Transaction in Own Shares
  2:12 pm
RNS
GSK increases its ownership in Theravance
15 May 2012 5:07 pm
RNS
Transaction in Own Shares
  10:00 am
RNS
GSK to fully acquire Cellzome
14 May 2012 5:19 pm
RNS
Transaction in Own Shares
11 May 2012 5:01 pm
RNS
Transaction in Own Shares
  3:25 pm
RNS
Director/PDMR Shareholding
  3:20 pm
RNS
Director/PDMR Shareholding
  3:16 pm
RNS
Director/PDMR Shareholding
10 May 2012 5:33 pm
RNS
Transaction in Own Shares
  1:00 pm
RNS
GSK commences tender offer to acquire HGS
09 May 2012 6:28 pm
RNS
Blocklisting Interim Review
  6:09 pm
RNS
Doc re. (AGM Statement)
  5:35 pm
RNS
Transaction in Own Shares
  7:00 am
RNS
GSK to commence tender offer to acquire HGS
08 May 2012 5:59 pm
RNS
Director/PDMR Shareholding
  5:55 pm
RNS
Director/PDMR Shareholding
  5:49 pm
RNS
Transaction in Own Shares
  2:47 pm
RNS
Director/PDMR Shareholding
  1:23 pm
RNS
Director/PDMR Shareholding
04 May 2012 5:04 pm
RNS
Transaction in Own Shares
  3:09 pm
RNS
Director/PDMR Shareholding
03 May 2012 5:44 pm
RNS
Result of AGM
  5:39 pm
RNS
Director/PDMR Shareholding
  5:24 pm
RNS
Transaction in Own Shares
  1:30 pm
RNS
Directorate Change
02 May 2012 5:31 pm
RNS
Transaction in Own Shares
01 May 2012 5:40 pm
RNS
Transaction in Own Shares
  2:40 pm
RNS
Total Voting Rights
30 Apr 2012 5:03 pm
RNS
Transaction in Own Shares
  4:20 pm
RNS
Director/PDMR Shareholding
  1:03 pm
RNS
Director/PDMR Shareholding
27 Apr 2012 5:04 pm
RNS
Transaction in Own Shares
  12:47 pm
RNS
Director/PDMR Shareholding
26 Apr 2012 5:18 pm
RNS
Transaction in Own Shares
  12:02 pm
RNS
Director/PDMR Shareholding
25 Apr 2012 12:00 pm
RNS
1st Quarter Results
20 Apr 2012 4:10 pm
RNS
Director/PDMR Shareholding (Replacement)
  3:50 pm
RNS
Director/PDMR Shareholding
  3:38 pm
RNS
Director/PDMR Shareholding
  2:46 pm
RNS
Director/PDMR Shareholding
  12:30 pm
RNS
GSK update on divestment of non-core OTC brands
19 Apr 2012 4:00 pm
RNS
Director/PDMR Shareholding
18 Apr 2012 4:26 pm
RNS
Director/PDMR Shareholding
  4:23 pm
RNS
Director/PDMR Shareholding
  3:40 pm
RNS
Director/PDMR Shareholding
  3:35 pm
RNS
Director/PDMR Shareholding
  3:27 pm
RNS
Director/PDMR Shareholding
16 Apr 2012 6:11 pm
RNS
Director/PDMR Shareholding (Replacement)
  3:54 pm
RNS
Director/PDMR Shareholding
  12:23 pm
RNS
Director/PDMR Shareholding
  11:14 am
RNS
Director/PDMR Shareholding
13 Apr 2012 4:49 pm
RNS
Director/PDMR Shareholding
  4:46 pm
RNS
Director/PDMR Shareholding
  4:43 pm
RNS
Director/PDMR Shareholding
  4:25 pm
RNS
Director/PDMR Shareholding
03 Apr 2012 7:00 am
RNS
GSK receives further phase 3 data for albiglutide
02 Apr 2012 5:22 pm
RNS
Director/PDMR Shareholding
  5:17 pm
RNS
Director/PDMR Shareholding
  5:10 pm
RNS
Director/PDMR Shareholding
  12:29 pm
RNS
GSK to increase its ownership in Theravance
  12:08 pm
RNS
Total Voting Rights
  7:00 am
RNS
Phase lll study of dolutegravir in HIV announced
28 Mar 2012 4:55 pm
RNS
Transaction in Own Shares
27 Mar 2012 5:04 pm
RNS
Transaction in Own Shares
26 Mar 2012 5:17 pm
RNS
Transaction in Own Shares
  2:43 pm
RNS
Notice of AGM
23 Mar 2012 5:06 pm
RNS
Transaction in Own Shares
  11:03 am
RNS
Annual Information Update
22 Mar 2012 11:19 am
RNS
Director/PDMR Shareholding
19 Mar 2012 4:02 pm
RNS
Director/PDMR Shareholding
16 Mar 2012 5:05 pm
RNS
Transaction in Own Shares
15 Mar 2012 5:33 pm
RNS
Transaction in Own Shares
  9:30 am
RNS
GSK update on divestment of non-core OTC brands
14 Mar 2012 5:09 pm
RNS
Transaction in Own Shares
  10:49 am
RNS
GSK files its Annual Report 2011 on Form 20-F
13 Mar 2012 5:50 pm
RNS
Transaction in Own Shares
  4:35 pm
RNS
Director/PDMR Shareholding
12 Mar 2012 5:27 pm
RNS
Transaction in Own Shares
  3:35 pm
RNS
Annual Financial Report
  3:26 pm
RNS
Director/PDMR Shareholding
  3:25 pm
RNS
Director/PDMR Shareholding
09 Mar 2012 5:31 pm
RNS
Transaction in Own Shares
  5:21 pm
RNS
Director/PDMR Shareholding
  5:18 pm
RNS
Director/PDMR Shareholding
  3:21 pm
RNS
Director/PDMR Shareholding
  9:24 am
RNS
Director/PDMR Shareholding
08 Mar 2012 5:36 pm
RNS
Transaction in Own Shares
07 Mar 2012 6:13 pm
RNS
Replacement Director/PDMR Shareholding
  5:09 pm
RNS
Transaction in Own Shares
06 Mar 2012 5:13 pm
RNS
Transaction in Own Shares
05 Mar 2012 5:16 pm
RNS
Transaction in Own Shares
  2:35 pm
RNS
Director/PDMR Shareholding
  2:16 pm
RNS
Replacement Announcement Transaction in Own Shares
02 Mar 2012 5:15 pm
RNS
Transaction in Own Shares
  7:00 am
RNS
GSK and Daiichi Sankyo to form joint venture
01 Mar 2012 5:34 pm
RNS
Transaction in Own Shares
  11:18 am
RNS
Total Voting Rights
29 Feb 2012 5:38 pm
RNS
Transaction in Own Shares
28 Feb 2012 5:49 pm
RNS
Transaction in Own Shares
27 Feb 2012 6:05 pm
RNS
Transaction in Own Shares
24 Feb 2012 5:41 pm
RNS
Transaction in Own Shares
23 Feb 2012 5:50 pm
RNS
Director/PDMR Shareholding
  5:27 pm
RNS
Transaction in Own Shares
22 Feb 2012 5:44 pm
RNS
Transaction in Own Shares
21 Feb 2012 5:29 pm
RNS
Transaction in Own Shares
  4:34 pm
RNS
Director/PDMR Shareholding
  4:29 pm
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
20 Feb 2012 6:27 pm
RNS
Director/PDMR Shareholding
  6:23 pm
RNS
Director/PDMR Shareholding
  6:06 pm
RNS
Director/PDMR Shareholding
  5:55 pm
RNS
Transaction in Own Shares
17 Feb 2012 5:22 pm
RNS
Transaction in Own Shares
  5:07 pm
RNS
Director/PDMR Shareholding
16 Feb 2012 5:42 pm
RNS
Transaction in Own Shares
  11:55 am
RNS
Dist. of cash amount on ords of GlaxoSmithKline
15 Feb 2012 5:44 pm
RNS
Transaction in Own Shares
14 Feb 2012 5:37 pm
RNS
Transaction in Own Shares
13 Feb 2012 5:27 pm
RNS
Transaction in Own Shares
10 Feb 2012 5:10 pm
RNS
Transaction in Own Shares
  4:45 pm
RNS
Director/PDMR Shareholding
  12:38 pm
RNS
Director/PDMR Shareholding
  12:32 pm
RNS
Director/PDMR Shareholding
09 Feb 2012 5:18 pm
RNS
Transaction in Own Shares
08 Feb 2012 5:59 pm
RNS
Transaction in Own Shares
  3:51 pm
RNS
Director/PDMR Shareholding
07 Feb 2012 2:20 pm
RNS
Director/PDMR Shareholding
  12:00 pm
RNS
Final Results
06 Feb 2012 5:38 pm
RNS
Director/PDMR Shareholding
03 Feb 2012 6:04 pm
RNS
Replacement Director/PDMR Shareholding
  4:59 pm
RNS
Replacement Director/PDMR Shareholding
01 Feb 2012 3:11 pm
RNS
Director/PDMR Shareholding
  1:55 pm
RNS
Total Voting Rights
31 Jan 2012 4:39 pm
RNS
Director/PDMR Shareholding
27 Jan 2012 10:59 am
RNS
GSK announces changes to its Board
23 Jan 2012 6:03 pm
RNS
Director/PDMR Shareholding
20 Jan 2012 9:56 am
RNS
Additional Listing
19 Jan 2012 6:18 pm
RNS
Director/PDMR Shareholding
17 Jan 2012 2:05 pm
RNS
Director/PDMR Shareholding
16 Jan 2012 4:47 pm
RNS
Director/PDMR Shareholding
13 Jan 2012 6:08 pm
RNS
Director/PDMR Shareholding
  6:05 pm
RNS
Director/PDMR Shareholding
12 Jan 2012 4:04 pm
RNS
Director/PDMR Shareholding
  4:00 pm
RNS
Director/PDMR Shareholding
  3:57 pm
RNS
Director/PDMR Shareholding
10 Jan 2012 6:32 pm
RNS
Director/PDMR Shareholding - Replacement
  6:22 pm
RNS
Director/PDMR Shareholding - Replacement
  5:51 pm
RNS
Director/PDMR Shareholding
  5:47 pm
RNS
Director/PDMR Shareholding
  5:44 pm
RNS
Director/PDMR Shareholding
  5:41 pm
RNS
Director/PDMR Shareholding
  5:38 pm
RNS
Director/PDMR Shareholding
09 Jan 2012 6:27 pm
RNS
Director/PDMR Shareholding
  6:00 pm
RNS
Director/PDMR Shareholding
  4:43 pm
RNS
Director/PDMR Shareholding
  12:51 pm
RNS
Director/PDMR Shareholding
  7:01 am
RNS
Initial outcomes of Phase III studies for Relovair
06 Jan 2012 4:35 pm
RNS
Director/PDMR Shareholding
  4:32 pm
RNS
Director/PDMR Shareholding
  4:29 pm
RNS
Director/PDMR Shareholding
03 Jan 2012 5:30 pm
RNS
Director/PDMR Shareholding
  4:17 pm
RNS
Total Voting Rights
  3:50 pm
RNS
Director/PDMR Shareholding
  12:30 pm
RNS
Director/PDMR Shareholding
22 Dec 2011 3:00 pm
RNS
Director/PDMR Shareholding
  10:43 am
RNS
Director/PDMR Shareholding
21 Dec 2011 6:15 pm
RNS
Director/PDMR Shareholding
  6:10 pm
RNS
Director/PDMR Shareholding
20 Dec 2011 5:02 pm
RNS
Director/PDMR Shareholding
  1:15 pm
RNS
Update on divestment of non-core OTC brands
13 Dec 2011 5:19 pm
RNS
Transaction in Own Shares
12 Dec 2011 5:49 pm
RNS
Director/PDMR Shareholding
  5:27 pm
RNS
Director/PDMR Shareholding
  5:22 pm
RNS
Director/PDMR Shareholding
09 Dec 2011 4:43 pm
RNS
Director/PDMR Shareholding
07 Dec 2011 4:55 pm
RNS
Transaction in Own Shares
06 Dec 2011 5:17 pm
RNS
Transaction in Own Shares
05 Dec 2011 5:00 pm
RNS
Transaction in Own Shares
02 Dec 2011 5:14 pm
RNS
Transaction in Own Shares
  3:57 pm
RNS
Director/PDMR Shareholding
  3:54 pm
RNS
Director/PDMR Shareholding
  3:51 pm
RNS
Director/PDMR Shareholding
  3:38 pm
RNS
Director/PDMR Shareholding
01 Dec 2011 5:14 pm
RNS
Transaction in Own Shares
  12:15 pm
RNS
Total Voting Rights
  12:00 pm
RNS
Reporting on core basis from Q1 2012
30 Nov 2011 5:23 pm
RNS
Transaction in Own Shares
29 Nov 2011 5:00 pm
RNS
Transaction in Own Shares
28 Nov 2011 5:04 pm
RNS
Transaction in Own Shares
  4:22 pm
RNS
Director/PDMR Shareholding
25 Nov 2011 5:16 pm
RNS
Transaction in Own Shares
24 Nov 2011 5:15 pm
RNS
Transaction in Own Shares
23 Nov 2011 5:35 pm
RNS
Transaction in Own Shares
22 Nov 2011 5:07 pm
RNS
Transaction in Own Shares
21 Nov 2011 5:04 pm
RNS
Transaction in Own Shares
18 Nov 2011 5:18 pm
RNS
Notifiable Share Interest in OctoPlus N.V.
  5:08 pm
RNS
Transaction in Own Shares
17 Nov 2011 4:50 pm
RNS
Transaction in Own Shares
16 Nov 2011 5:10 pm
RNS
Transaction in Own Shares
15 Nov 2011 5:18 pm
RNS
Transaction in Own Shares
14 Nov 2011 5:45 pm
RNS
Director/PDMR Shareholding
10 Nov 2011 5:24 pm
RNS
Transaction in Own Shares
  5:21 pm
RNS
Director/PDMR Shareholding
  5:20 pm
RNS
Director/PDMR Shareholding
  1:10 pm
RNS
Director/PDMR Shareholding
  1:07 pm
RNS
Director/PDMR Shareholding
09 Nov 2011 5:39 pm
RNS
Transaction in Own Shares
08 Nov 2011 5:45 pm
RNS
Blocklisting Interim Review
  5:44 pm
RNS
Transaction in Own Shares
07 Nov 2011 5:49 pm
RNS
Transaction in Own Shares
  4:46 pm
RNS
Director/PDMR Shareholding
04 Nov 2011 6:10 pm
RNS
Director/PDMR Shareholding
  6:06 pm
RNS
Director/PDMR Shareholding
  5:35 pm
RNS
Transaction in Own Shares
  5:15 pm
RNS
Director/PDMR Shareholding
03 Nov 2011 6:26 pm
RNS
Notifiable Share Interest in Theravance, Inc.
  6:22 pm
RNS
Transaction in Own Shares
  7:02 am
RNS
GSK reaches settlement with US Government
02 Nov 2011 5:58 pm